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blood transfusion has become a comparatively
safe procedure and is now regarded as invaluable
in modern medicine and surgery. The discovery of
blood groups, improved methods of collection,
storage and preservation of blood as veil as
recent developments in cross-matching techniques
have all helped to reduce the risks attached to
the transfusion of blood.
In earlier days, the main disadvantage was
lack of knowledge of -
(1/ Aseptic technique
(2; blood groups I compatibility; and their
immunological relationships
(S; Coagulation mechanism
(4; Methods of preservation and storage of
blood (blood banking;
These problems have been gradually solved by
several workers in this field and as a result
there has been a marked increase in the number of
transfusions. ihls has confronted present day
workers with a further problem, namely iso-
immunisarion which may be defined as immunisation
of an individual by antigens from the same species,




The first authenticated transfusion in man
was probably performed oy Denis (1667; who
successfully transfused the blood of a lamb into a
youth. «is second and third transfusions ;ere
also carried out seemingly without any adverse
effect, but the patient of his fourth attempted
transfusion died and he was charged with murder,
following this incident, transfusion was pro-
shibited and as a result, interest in transfusion
ceased for a century and a half vhen Blundell(1818)
a London physiologist and obstetrician revived the
procedure. ne successfully transfused blood to
three patients ith post-partum haemorrhage and
advocated transfusion in the treatment of acute
haemorrhage. Be also insisted that human blood
was more effective than th"t of «nimal origin.
Blundell's work led to an understanding of the
rationale of transfusion. At the beginning of
the last quarter of the nineteenth century, several
British ' n.d American workers (Winants 1872,
Barnes 1874, Gredle 1874, Sittel 1874, Hotz 1875)
practiced transfusion again with animal blood and
without any due regard to the previously est'blishe
fundamental principles regarding the indications
for blood transfusion and met with tne inevitable
severe reactions. Because of these fatal reactions
many/
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many of which sere duo to lncompatlbilifcy,.blood
transfusion practice was ones mors pr ctically
ab ndcneci during the last quarter of Lhe nineteenth
century.
viscovery of the AbO Blood Croups and Their
Application In Blood Transfusion
Aiandsteiner (1900, 1901) first discovered the
agglutination of the red cells of some individuals
by the sera of others and on the basis of such
reactions he classified human erythrocytes into
three different and distinct groups A, b, and 0.
Von wecsstello and Sturli (1902) discovered the
fourth group An. These epochal discoveries
helped to eliminate incompatibility, one of the
most difficult problems so far encountered.
Ottenberg (1911) first applied this knowledge of
ABO blood groups in transfusion practice.
Discovery of Anticoagulants and Preservatives
and the Operation of blood b ' nks
Although the main cause of fatal reactions
had been found as a result of the discovery of
the ABO blood groups and methods of prevention
had been demonstrated, inconvenience due to
coagulation and infection still persisted. To
avoid coagulation, Carrel (1907) and Bernheim (1909)
tried transfusion by bringing the blocd in direct
contact/
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contaot with the intlms of the blood vessels by
erterio-venous anastomosis. This process was
difficult end thus failed to gain popularity and
as a result fe? transfusions ere carried out in
comparison with the need.
In 1914, sodium citrate as first introduced
as an anti-coagulant by Austin (1914) and very soon
afterwards by Agote (1915), Lewisohn (1915) and
Weil (1915) and thus it was possible to separate
the collection of blood from its injection, which
permitted for the first time, the so-called "delayed
transfusion' (DeGwin et el. 1949). This pro¬
cedure soon gained popularity and was used
extensively in World War I.
Rous and Turner (1916) published their pioneer
work on the using of dextrose as a preservative of
blood for transfusion and, making use of their
findings, Robertson (1918) operated the first blood
bank in the casualty clearing stations of the British
Army.
After 18orld sr I, the principle of blood bank
had been temporarily forgotten until the third
decade of the present century while several Russian
investigators (Skundina and Barenboim, Skundina,
Rusakov and Ginsberg, cited by Kllduffe and DeBakey, 1942;
Yudin 1936) revived the procedure using cadaver blood.
In/
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In 1932, Skundina end Barenboim demonstrated that
•when cadavers were preserved at a temperature of
1 to 2° above zero, the blood In the cadaver vessel!
preserved Its "living properties" for six to seven
hours. Following these studies, a variety of methods
for the collection, preservation and storage of blood
for transfusion have been developed.
During the Spanish Civil war in 1936, the
Loyalist forces developed the transportation of
preserved blood (Jorda 1939j. The present form of
the blood Transfusion services has developed during
and after orId *ar II.
Aseptic Controls and Discovery of pyrogens.
genj
Gradual development of aseptic techniques,
methods of sterilisation and closed systems of
withdrawal and transfusion of blood (Kolmer 1924,
batton 1938, csharpe 1939; have considerably minimized
the hazards due to infection. Seibert (1923; firs
observed that a heat stable bacterial product (pyro
was responsible for some of the febrile reactions
folio ing even ABO compatible blood transfusion,
xt was however found that these reactions could be
avoided if certain precautions were taken.
rollovlng the discoveries of the ABO groups,
anticoagulants and preservatives and the development
of aseptic techniques and bacterial control, blood
transfusions/
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transfusions were practiced more frequently and the
risk 8s a result of iso-lmmunlsation then became
evident.
Xso-immunisetion in Man and Animals
The phenomenon of iso-immunisation was first
discovered by JShrlich and Morgenroth (1900). They
observed that if the haemolysed blood of one goat
were injected to other goats, the sera of the in-
:jected goats were characterised by the presence of
immune antibody (haemolysinj. By this method of
immunisation, they were able to prove that the red
cells of individual animals within the same species
ere of different serological properties. Iso-
immunisation has since been practiced in many other-
animals by the same procedure and remarkable
specificity of red cells has been observed. Although
the discovery of the ABO blood groups coincided
with the discovery of 1so-immunisetion, the findings
in animals could not be at first correlated with the
findings in man. In animals, every individual
was characterised by serological specificity of its
red cells whereas in man it was limited to only
four main blood groups and subdivisions of group A,
first discovered by von Dungern and Hirszfeld (1911)
Iso-immunisation in human beings was first reported
by Deinst (1905) who observed rising of anti-A and
anti-B/
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anti-B agglutinins in recently delivered women of
group u after the birth of infants belonging to
group A or B.
The phenomenon of Iso-immunisation could not be
explained successfully in man by repeated trsns-
:fusions even at later periods when the transfusions
were carried out in greater numbers. Although it
was suspected on clinical grounds that patients
receiving repeated transfusions showed a higher
incidence of severe reactions, the actual proof of
iso-immunisation - the demonstration of atypical
immune antibodies - could not be supplied until
lately. Landsteiner and Levine (1927) used a new
immuno-logical procedure namely, hetero-immunisation
and discovered the M, N, and P agglutinogens by
immunising rabbits with hum-n blood cells. These
discoveries served to bridge the gap between the
findings in man and animal and emphasised the
analogy of individuality of human erythrocytes.
Discovery of Rh factor and its Role in Transfusion
and Haemolytlc Disease of the Newborn.
During the period of 1921-40 a number of cases
were reported where heemolytic transfusion reactions
had occurred despite the transfusion of blood of
correct ABO groups (Unger 1921, Landsteiner et el.1928,
Zscho 1956, Culbertson and Katcliffe 1936, Neter 1956,
Levine and Stetson 1939)./
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Levine & Stetson 1939). In some of these cases It
was possible to demonstrate the presence of atypical,
antibodies. Most of these atypical antibodies were
unrelated to ABO groups or MN factors though some
designated as G, H, K, Q, (Andresen 1935) were
probably associated with t agglutinogen. To
demonstrate additional factors by immunisation of
animals Landsteiner and Wiener(1937) injected
rabbits with Rhesus Monkey red cells which produced
anti-M antibodies. Continuing this line of work
Landsteiner and Wiener(1940) immunised rabbits and
later guinea-pigs with the blood of the monkey
Macscus rhesus and found that some of the antisera
thus produced agglutinated the red cells of 85$
of white people. Those that were agglutinated
they called Rhesus positive and the remaining 15$
Rhesus negative and to the new factor they applied
the symbol Kh.
The discovery of the Rh factor not only
explained the cause of hemolytic transfusion
reaction but also helped in understanding the
aetiology of haemolytic disease of the newborn,
which was hitherto obscure though some investigators
suggested that it might be the result of an antigen
antibody reaction. Darrow(1938) in describing
the pathogenisis of congenital haemolytic disease
(haemolytic/
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(haemolytic disease of the newborn), had
postulated the iso-immunisation of the mother to
foetal haemoglobin and thought that this led to
the passage of resulting antibodies across the
placental barrier into the blood stream of the foetus,
Levine and Stetson(1939) published an interesting
case report of a multipara group 0 woman who
delivered a 33 week stillbirth. For post-partum
haemorrhage, she was transfused with 500 ml. of her
husband's blood (also of group 0). Immediately
following the transfusion, she had a severe reaction.
Using a more sensitive method it was found that her
serum contained an antibody which agglutinated the
red cells of her husband and those of 80 out of
104 group 0 donors. From this observation the
authors deduced "that the mother has been immunised
by a foetal antigen inherited from the father and
had received blood against which she had already
formed antibody". This observation slightly
differed from that of Darrow(1938) because it
mentioned the possibility of immunising the mother
by a 'new* blood factor present in the foetus and
inherited from the father.
Levine and Katzin(1940) reported several
additional instances of transfusion reactions
associated/
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associated with iso-immunisation to the Rh factor
during pregnancy and were able to shov that the
case of Levine and Stetson(1939) was the result of
nh -irarnunisation. Wiener and Peters(1940) using
anti-Rh -rabbit serum prepared by Landsteiner and
Wiener(1940) established that four cases of
haemolytic reactions following repeated transfusions
of ABO compatible blood, were due to incompatibility
in the Rh system. Xn three of these cases the
sera were shown to contain an agglutinin for the
Kh-positive human erythrocytes which corresponded
in agglutinating properties to the anti-Rh-rabbit
sera of Landsteiner and Wiener. Levine, Katzin
and Burnham(1941) and Levine, Katzin, Burnham and
tfogel(1941) were then able to demonstrate that
«h-immunisation was of importance in the aetiology
of erythroblastosis foetalis (haemolytic disease
of the newborn; and of some stillbirths and
miscarriages. In a statistical study, Levine
and his associates(1941) found that 91 of 111
mothers of erythroblastotic infants were Kh-negative
as compared with only 15% Rh-negative in the
population at large, and that 100$ of 66 fathers
and 58 affected infants were Kh-positive as
compared with 85% Rh-positive individuals in the
population. Of the Rh-negative mothers about
b0%/
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50$ showed antl-Rh agglutinins when tested two
months after delivery of an infant with erythro-
iblastosis foetalis. it thus appeared that about
90% of the cases of erythroblastosis foetalis
could be accounted for on the basis of iso-
immunlsation due to the Kh factor.
Varieties of Kh
The importance of the Rh factor was soon
realised and several American and British workers
■
carried out a great number of investigations and
demonstrated that all anti-Hh sera were not
identical in every respect. iievine( 1942) showed
that one serum which agglutinated 87$ of bloods
among the population in New York contained two
agglutinins which he designated Rh-| and Rh^.
forking with new testing sera, Wiener(1944a) found
six principle genes which he called rh, Rh0, Rh',
Rh", Rh^, Riu. Of these genes, RhQ is the one
responsible for the antigen detected by the
original rabbit and guinea pig anti-Rh sera. The
six genes in the series give rise to six antigens
producing six antisera - anti-Rb0, anti-Rhf, anti-Rh",
anti-lih^, anti-Rh^ and anti-Hr (Levine 1941).
The latter IJKh reversed; was used by Wiener to
signify sera which reacted with Kh-negative bloods
i.e. (rh/rh etc.).
The British Classification of Rhesus Blood Groups
About/
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About the same time as Wiener(1944a) in America
was reclassifying the Rhesus blood groups, Race and
Taylor(1943) and Race, Taylor, Boorman and Dodd(1943)
in this country using a strong anti-Hr serum had
produced a similar classification of the Rh genes,
Pisher (cited by Race 1944/ then noticed that if
a gene was positive with anti-Hr serum it was
negative with anti-Rh' serum. He supoosed that
the antigens responsible for these reactions were
"
allelomorphic genes which he labelled c and C
respectively. He further suggested that the
I
anti-Rh^ serum was produced by a gene D which had
an allelomorph d and that anti-Rh" serum was the
result of a gene E with an allelomorph e. This
theory presupoosed the existence of three loci on
the chromosome which are responsible for the Kh
characteristics. This new scheme using the
letters Cc, Dd, «nd Be instead of Kh0 etc. was
published by Race(1944) and is known as the Pisher-
ilace classification.
Now the Kh chromosomes could be combined In
eight different ways namely, CDe, cDE, cde, cDe,
cdil, Cde, UD/s, Cd£.
The main difference between Wiener's and
Fisher's theory may be summerlsed in the words of
Mourant(1957J that each of the Rh antigens "reacts
specifically/
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speclflcally with a single well-defined antibody
or hseraoagglutinin. While antigenically these
entities are distinct, genetically they are
invariably transmitted in groups of at least two
and usually of three or more. Wiener regards
each genetically combined group of antigens as a
single antigen and considers that it is transmitted
by a single gene, whereas Fisher and Hsce regard
each elementary antigen as the product, probably,
of a separate gene."
Since it is awkward to speak of "big G, big D,
little e", certain short symbols for the various
combinations of elementary genes are widely used.
These short symbols, Wiener's and Fisher's
nomenclatures of the Rh gene combinations and their
frequencies for an English population (Race, Mouranfc
et al.1948) are shown in the following table
-14-
Short symbol Oene combinations Frequency
Wiener Fisher
Ki Hh1 CDe 0.4076
r rh ode 0.5886
Bhg oDK 0.1411
Ro a„ cDe 0.0267
R" Rh" cdK 0,0119
R' Rh» Ode 0.0098
Rz CDfc; rare
R
y Rhy CdS rare
Fisher's and Wiener's terminology of the
antibodies oorresconding to the six el-
:ementary Rh antigens are given below









Plsher's nomenclature will be primarily
folio.ed throughout the text unless other¬
wise stated. (Where the term hh-positive
or Rh-negatlve has been used, it should




The discovery of anti-e by Mourant(1945)
supported Fisher's hypothesis. Anti-d wpe first
reported by Diamond(1946) and subsequently by
Hill and Haberman(1948J and since it had been
found mixed with other antibodies and also for its
infrequent occurrence, V,iener(1950) expressed
doubt about its existence.
Rosenfield and his asscci^tesl^SS) discovered
a new Rh a-itlgoi f with the sera of a haemophiliac
who hod received 55 previous transfusions.
Race and Sanger(1954) suggested that "anti-f
I and the antigen it determined would easily and
comfortably fit in with what as already known
\
of the Rh system if only a fourth series of
allelomorphlc antigen were postulated". After
the discovery of three pairs of elimentary
antigens Dd, Cc, fie, (excluding the recently
discovered f antigen; several other allelomorphs
have been reported by different workers e.g.
Cw (Callender fic Race,1946), cv, Cu (Race and his
co-workers,1948/, Gx (Stratton and Renton,1954)
as third, fourth, fifth and sixth allelororphs
respectively at the loci of Cc; Du (Strstton,1946)
as the third antigen a 1lelomorphlc to Dd;
fiu(Ceppellini et al.(1950) and ex (Gilbey,1950)
as the third and fourth allelomorphs to Ee locus.
Of these allelomorphs, only 0* end Du are
important/
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important. 'l'here are therefore, three sets of
important alleles or antigens CCvc, Dud, Ee;
the various genes excluding Du occur in 12
different combinations on each chromosome and
these chromosomes are in order of frequency
vJDe, cde, cDK, cDe, CwDe, cdJS, Gde, CDS, C*de, Gdl
CWDE, Cv'dis. Since each cell in adult organism
has two such chromosomes there are 12(12+1j=78
possible genotyoes of which 26 major types can be
recognised.
Discovery of Methods for Detection of Incomplete
Antibodies.
During the first four years of Kh work, the
workers in this field were puzzled because, even in
instances of proven haemolytic transfusion
reaotions or definite erythroblastosis foetalis,
the serum of the affected individual failed to
disclose Rh agglutinins. Diamond(1944a) first
noted that a concentrated globulin preparation
from an Kh antiserum was capable of in?-ctlvr ting
an anti-Rh saline-acting antibody of high titre.
He also observed a prozone effect in this
preparation. .these observations suggested that
there might be a 'new' type of Rh antibody which
not only differed from the original Kh antibody -
agglutinin - but also hod some inhibitory effect




Race(1944) and Wiener(1944b) explained the nature
of this phenomenon. both observers noted the
•blocking' effect of this type of antibody on
saline agglutinin; Race and Wiener called it
incomplete and blocking antibody respectively.
Following these observations three principle
methods for the detection of incomplete antibodies
were developed namely, Albumin method (Diamond and
Denton,1945), Anti-human globulin method (Coombs
et al. 1945) and Enzyme-treated cell method
(Pickles 1946; Morton and Pickles 1947).
Discovery of flew Blood Group Systems other than Rh.
During the World War XI, blood transfusion
h8d been practised to a large extent and this had
led to the better understanding of its value as a
therapeutic weapon. With the post-war reorganisation
of the Blood Transfusion Services, blood hss become
more readily available and it is nov being used for
a variety of conditions. it has been proved to
be a life saving procedure in acute haemorrhage;
in some cases of blood dyscrasi^s it is the only
method of prolonging the life of the patient.
Moreover, blood transfusion has played a great role
in the development of cardiac and thoracic surgery
in recent years. All these factors are responsible
for the enormous increase in the number of trans-
:fusions during the post-war period. The
knowledge/
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knowledge of the aetiology of intragroup trans-
:fuslon reactions and haemolytic disease of the
newborn and the application of the newly discovered
and more sensitive methods (especially Coombs'
technique) have led to the discovery of several
new blood factors in recent, years.
Callender and Race(1946) found the Lutheran
antibody in the serum of a patient suffering from
lupus erythematosus diffusus who had had several
transfusions. Coombs, Mourant and Race(1945)
reported the first example of anti-Kell in the
serum of a mother of a child suffering from
haemolytic disease. 'i'he authors designated the
antigen recognised by this antibody as Kell
factor (K) . Levine et al,(1949) first reported
the reciprocal factor Cellano(k). This was
recognised by the discovery of an antibody in the
serum of a mother of a child with mild hemolytic
disease which could not be accounted for by the
other blood factors. Only 5 of the 2,495 persons
tested were found to be Cellanc negative; four of
these were retested with anti-Kell serum and found
to be Kell-positive. These findings established
the reciorocal relationship between these two factors.
Mourant(1946) first discovered Levis factor Le' ,
detectable by an antiserum anti-Les, which agglutinated
about 20^ of the Caucasian bloods. Andresen(194B
reoorted the antiserum Lp which is now known as
anti-Leb and/
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and recognised the antigen Le10.
Sanger and Kace(l947) described anti-S and
showed that it was from an antigen associ-ted with
tS and N factors. Atrt s factor allelormorphic to S
I was first reported by Devine et al.(1951). The
antibodies anti-S and antl-s (recognising S and s
factors respectively) though related to the MN
system, have been found only in human serum,
hare instances of erythrocytes showing very weak
M or N agglutinogens have been reported suggesting
the presence of the subgroups Mc, but thes^
are of little clinical importance (Crome,1935;
Priedenreich and Laurisden,1938; Dunsford, Ikin
and Mourant,1953.) The very high incidence
factor U has recently been found to be related to
the Ss system (Greenw^lt et al.1954). Erythro¬
cytes of individuals who lack 0 are therefore uu
homozygous, do not react with anti-S or snti-s;
the symbol 3U has been proposed.
Cutbush, fliollison and Parkin(1950) discovered
the Duffy (Fy) blood group and the antibody was
found in a man suffering from haemophilia who had
had several blood transfusions. The Fy antigen
is present in about 65$ of the population. The
reciprocal factor Fy was recognised.by Ikin et al.
(1951); a woman was found two days after delivery
to have an antibody for her husband's and child's
erythrocytes/
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erythrocytes which did not correspond to any
known blood group antigens; no evidence of
haemolytic disease was found in the child and in
studies with a larger panel of red cells of
various individuals its reciorocal(allelic)
relation to Fyp was discovered. Allen, Diamond
and Niedziela(1951) discovered Kidd blood group.
The antibody was detected in the serum of
Mrs. Ridd., a multiparous woman whose sixth child
was the first in the family to suffer from
haemolytic disease. The antigen recognised by
this antibody is kno= n as «ik". The antithetical
antibody Jk^: was first found by Plaut and his
associates(1953). It was present in a wom^n who
had a rigor folio/.ing a transfusion after a
miscarriage. She had had one previous transfusiop
after her second delivery.
I
In addition to the nine blood group systems,
a number of additional blood factors have been
reported, but these are not clinically important
because the ^ntigens by which they are recognised
are nearly always absent(private family antigen;
or nearly al.ays present(public antigen).
The total number of different blood types
may be calculated by oermutation and combination
of the recognisable major types of nine main
blood grouo systems as follows:
blood group system/
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Total major types 6x26x9x5x2x5
x 3 x 5 x 2 = 454,896
These figures do not include Du, cv, cJ, Cz,
M , f<( , M , et. nor the distinctions made by& £* C
anti-d and the ne. antisera nnti-f. They
also do not include the 'private family' or
'public* antigens.
Problem
in practice only a few of the blood f'-ctors,
mentioned above, are taken into account in the
cross matching tests for routine blood transfusion
and therefore the chance of giving 'exactly
homologous' blood is very remote.
it is important to find out the actual
incidence of immunisation against blood factors
/hioh are not routinely screened because such
immunisations do not usually give rise tc
immediate complication, and doubt has been
expressed ib many quarters that blood transfusion
is practiced more frequently nowadays than is
actually needed without due regard to the
possibility/
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posslbillty of remote consequences.
So far the incidence of iso-immunisation due
to blood transfusion has been studied mostly on
selected c,!ses giving rise to transfusion reaction^
or cross matching difficulties. From the results
of such investigations it Is difficult to assess
the actual figure of iso-immunisetlon because,
after blood transfusion antibodies may develop
/ithout giving rise to any jreaction, and these
antibodies are likely to remain undetected unless
the patient requires further blood transfusion in
the future, and even then if proper screening
tests are not done.
The present study is therefore an attempt to'
find out the actual incidence of iso-immunisation
after routine blood transfusions by examining the
pre- and post—trensfusion samples of the recioientp
against a number of clinically important blood
group antigens. Another purpose was to compare
the different methods for the detection of blood
grouo antibodies and also to see the effect of
blood transfusion on so-called naturally occurring





Sterile physiological saline (0.9 gm$ sodium
chloride), hereafter referred to as saline.
Saline-Citrate fixture
A mixture of 2 parts of saline end one part
of 3.8% sodium citrate solution.
Albumin Solution
30$ solution of bovine albumin (Armour
Laboratories).
A 20$ working solution was m*de by taking
2 ml. of >0$ bovine albumin solution and adding to
it 1 ml. of saline-citrate mixture.
Phosphate Buffer
M/10 phosphate buffer, 7.7.
Proteolytic Enzymes
(A) Crystalline Trypsin (Armour Laboratories5
Batch No. 15347.
A stock solution of 1% crystalline trypsin
was made in N/20 hydrochloric acid.
(b) Powdered Papain (b.D.H.) batch No.
439808/560601.
Coombs 1 Serum
Anti-human globulin serum - prepared from
rabbit.
The stock serum was diluted vith saline to
its previously determined working strength e-ch
dayj and any portion of this diluted serum
remaining/
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remaining after each days work, was discarded.
Vihen not in use, the stock reagent and working
solution were kept frozen at -20°G.
Blood Group Anti-sera
(1) Standard anti-A, enti-b and saline
snti-D sera.
_ v.
(2) Anti-C, -E, -c, -e, -M, -N, -Le , -Le ,
-R, end anti-Py a.
V.hen the presence of an antibody was detected
in a patient's serum the recipient's and Donor's
cells (when available) were further tested ©gainst
these antibodies to obt- in as complete a genotype
as possible. All these antisera when not in use,
.ere kept frozen at -20°C.
Standard Test Cells
I
Group 0, K^R^, and rr cells, selected
also to include as many as possible of the
clinically important blood group antigens, obtaine
each day by finger prick from donor panel.
The cells were collected into graduated
centrifuge tubes containing saline-citrate mixture
centrifuged at §000 rpxn. for 10 minutes, and the
supernatant fluid replaced with saline; the
washing was repeated three times.
Saline and Albumin Suspension of Test Cells
2% suspensions were made by adding 0.1 ml.
of the previously washed packed cells to b ml. of
each/
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each media and they were used in saline and
albumin methods respectively.
Then not in use, these cell suspensions were
stored at 4°C. and any portion left after ec-ch
days work was discnrded.
RECIPIENT'S BLOOD
Pre-Transfuslon Samples
These included all blood specimens sent to
the Regional Blood Transfusion Centre for routine
compatibility tests from 4 surgical, 3 medical «nd
3 gynaecological wards. All the specimens
received from these wards were tested for the
| presence of antibodies and ore classed as Pre-
transfusion samples whether the patient hrd had
previous transfusions or not. After withdrawal,
these specimens were kept at 4°C. until tested -
usually 24 to 36 hours later.
A portion of the cells and serum was removed
by means of a pasteur pipette from the patient's
clotted specimen, transferred to another tube ond
centrifuged. The serum was separated and tested
for the presence of antibody while the cells were
washed three times in saline and were used for
determination of ABO groups, Rh type and in
autoagglutination control. A portion of the
cells was preserved in glycerol-citrste mixture
at/
-26-
at -20°G. for determination of the genet jpe when
required (because, in case of incompatible trans-
:fusion, it is difficult to determine the recipient1
genotype from the post-transfusion sample). The
method for freezing red cell in presence of
glycerol is discussed in Part II.
Post-Transfusion Samples
(A) first Examination - 10 to 14 days after
the patient had received a blood transfusion, a
sample of about 10 ml. of blood was withdrawn
using a dry sterile syringe. The blood was
allowed to clot at room temperature for one hour
and the tube was then centrifuged and the serum
separated and tested for the presence of antibody.
(B) Second Examination - In about half of the
esses, (the patient being still in the hospital)
it was possible to take another sample of blood
beteen 26th and 35th day following transfusion.
These samples were obtained and tested as described
under first examination.
Detection of Antibodies
An initial screening test for the detection




3/ Indirect snti-human globulin(Coombs' test)
4) Enzyme/
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4) Enzyme treated cell
(A) Trypsin
(B) Papain
Methods 1, 2, 3 and 4A are the s<*me as
recommended in MRC Memo., No. 27.
The method 4B using papain treated cells is
a simple modified method described later.
Saline Method
0.02 ml. of a suspension of each type of
standard test cells v.ere placed separately in
three 3" x §M test tubes. Equal volumes of serum
under test were added to e^ch tube and the contents
mixed by gentle shaking. Three sets of tests
were set up at three different temperatures,
4°0., room temperature and 37°C. After two hours
incubation the results were read meoroscopically
and confirmed by reading under the low power of a
microscope. For microscopical examination a
small amount of sedimented cell was transferred
on to a clean slide with the stem of a pasteur
pipette to give an even film.
Controls with D-oositlve and D-negative cells
against weak saline anti-D serum were set up and
their results were read before the tests. In
addition, autoagglutinin controls were put up




Tests were carried out and read in a similar
manner to that described in case of saline method,
except that the red cells were suspended in 20#
bovine albumin solution instead of in saline.
indirect Anti-human Globulin Method
Sensitization of cells: One volume (0.02)
of a 50# saline suspension of washed standard test
cells was placed into three separate test tubes
(3"xf") and five volumes of serum under test
added to each. The tubes were then incubated
for two hours at 37°G.
Washing of sensitized cells: After two
hours incubation, the cells were washed four times
in excess of saline and finally resusoended to
give an approximately 10# saline suspension.
Treatment of washed sensitized cells with
antl-human globulin serum; One drop of the 10#
cell suspension was added to one drop of diluted
working solution of Coombs' serum on a chemically
clean slide; and mixed by gently rotating the
slide. After one minute, the slide was inspected
for agglutination by gently tilting it backward
and forward; if no agglutination was observed
the slide was replaced on the bench until the
control test showed eak agglutination of the red




In parallel to the tests, three sets of
positive and negative controls were put up, using
known weak incomplete anti-D, -K and anti-Fyr sera.
For sensitization, the cells of the control
series were incubated at the same temperature and
for the same period of time as the tests.
Special Precautions
In order to avoid false positive and false
negative results, the following precautions were
taken.
As anti-human globulin combines with human
globulin at any state not only with antibody
globulin fixed to the red cells, meticulous care
was taken to avoid its contamination with even
minute trace of human serum. J.n diluting the
serum care was taken so that the apoaratus used
was not contaminated in any way. isvery time
freshly prepared pasteur pipettes were used for
diluting anti-human globulin serum and delivery of
ashed sensitized cells.
i'he microscopic slides used for the final
stage of the test were scrubbed well with soap end
hot water and then rinsed thoroughly under running
water. Finally they were dried with clean linen
not used for any other purpose.
Direct Anti-human Globulin Method
Direct anti-human globulin tests were done
on red cells of all post transfusion samples.
A/
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A portion of the recipient's red cells was
thoroughly washed four times in large volumes of
saline. One drop of the 10$ saline suspension
of the washed cells was mixed on a chemically
clean slide with a drop of suitably diluted anti-
human globulin serum, left for a minute and then
gently rocked and observed to see if any
agglutination occurred. As controls, cells
known to be unsensitized and cells sensitized with
fit
known weak anti-D, snti-K and anti-Fy ' were also
washed and treated with anti-human globulin serum.
The observation for agglutination was continued
for approximately 7 minutes with occasional
gentle rocking of the slide.
Trypsin-Treated Cell Method
On the day of use, one part of stock
solution of crystalline trypsin was diluted with
H
nine parts of M/10 phosphate buffer p 7,7.
For trypsinstion of cells, 4 volumes of diluted
trypsin solution were added separately to one
volume of each type of packed standard test cells
?hich have been washed three times. The tubes
were incubated in the water bath at 57°C. After
one hour incubation the cells were washed once
and resuspended in saline to give approximately a
5% suspension.
To avoid non-specific cold agglutinin reaction,
the/
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the cell suspension and the serum under test were
placed separately at 37°G. for 10 minutes. Then
equal volumes of serum and cell suspension were
mixed and incubated In the water bath at 37"C. for
further one hour and the results were read as in
the case of the saline method. Controls with
D-posltive and D-negative cells against weak
incomplete anti-D sera were put up in identical
conditions as the tests, and the results of
controls were read before these of the tests.
The activity of the stock trypsin solution
was found to be quite satisfactory up to eight
weeks after which slight deterioration in its
acitivity was observed and therefore fresh stock
solutions were prepared at the end of that period.
Papain Method
The following simplified papain method was
used by Tribedi and Crosbie (an unpublished
observation) in an investigation in which they
tested 1,116 random blood samples for Rh(D)
typing, 540 sera of antenatal cases for the
detection of antibodies and 84 specimens involving
240 bottles of blood for compatibility testing and
found that the results obtained by this papain
method were better than those by albumin method




During the present investigation it was found
that when red cells were treated with saline
suspension of papain without the addition of an
activator or buffer, and incubated with an anti¬
serum for a few minutes at room temperature, good
agglutination was observed. Preliminary tests
were carried out to determine the strength of
papain solution and time of exposure of the red
cells to the action of papain which would best
suit the required conditions namely, a simple
technique which would give the maximum specific
agglutination in a time "hlch compared favourably
with the existing standard methods. From the
results of these tests it was decided to use a
solution of 1% papain and incubate the red cells
(10% saline suspension) for a minimum time of 5
minutes. It was found that non-specific
agglutination apoesred after 2 to 4 hours when
the cells were exposed to papain solution, but
they retained their specificity for 24 hours if
washed once vithin that period. A washed cell
suspension was therefore prepared by adding 1%
papain solution to a 10% suspension of test cells,
incubating at room temperature for 5 to 10 minutes
and washing once with saline. It should be
mentioned in this connection that when cell
suspensions were to be used soon after the
addition/
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additlon of papain,as In Kh (D) typing and cross
matching tests, unwashed papain treated cells were
found to give satisfactory results.
The activity of the papain solution stored
at 4°C, remained satisfactory up to 24 hours after
preoaration, but after this period it began to
deteriorate rapidly. Fresh papain solution was
therefore prepared daily by distributing 0.1 mg.
of powdered papain into separate stoppered tubes,
and each day, 10 ml. of saline was added to one
tube. The tube was then shaken to obtain an even
suspension and centrlfuged to get rid of particuls
matters. The supernatant was transferred to a
fresh tube and kept at 4°C. when not In use.
This constituted the working papain solution for
24 hours.
Technique
0.02 ml, of 10% suspension of papslnised
standard test cells were placed separately in
three 3"xf" test tubes and equal volumes of
patients serum added to each tube. The contents
were mixed by shaking and incubated at 37°0. for
one hour. The results were read macroscoplcally
by tilting the tubes and confirmed by microscopic
reading. (After addition of the serum to the
pappInlsed cell, agglutination was observed
within 10 minutes but for the sake of convenience,
1 hour
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1 hour incubation period was selected for the
present series).
The following controls v.ere set up with the
tests.
1. Positive control
Equal volumes of 10% suspension of papainised
group U, GDe/CDe cells in saline and weak incomplete
anti-D.
2. Negative control
Equal volumes of 10'$ suspension of papainised
group 0, cde/cde cells in saline and weak incomplete
anti-D.
Titration
Vihen any antibody was found it was titrated
against appropriate cells by using a doubling
dilution method and the results are expressed in
terms of arbitrary scale as recommended in ^KC
memo., No.27.
The last tube giving at least a (-#-) reaction
(clumps of 8 to 12 cells) is recorded as the titre.
Identification of Antibodies
&hen an antibody was detected in recipient's
serum, the following methods were used for its
identification.
1. Genotyping of the recipient's cells as fully
as possible.
■
2. Genotyping of the donor's celis suspected to
contain/
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contsin the offending antigen.
3. Testing the serum against a panel of cells,
some containing and some without the
antigen against which the antibody wps
suspected.
4. Absorption and islution Techniques.
Genotyping of the Keolpient's and Donor's Cells
The cells of the recipient and donor (when
available) were genotyped with regard to the
antigens of the ABO, MNS, Rhesus, Lewis, Kell
and Duffy blood group systems. «ith the
exceptions of anti-A, anti-B and anti-D, all the
sera used were rare and therefore used in small
quantities. Pasteur pipettes were marked to
dellverO.OOB ml. and used for both sera and cells.
Saline method was carried out in oases of all anti-
sera except antl-Kell and anti-Duffy in which
Coombs* method was used. For the tests of A, B,
a ID
0, M, N, Le" and Le antigens the tubes '-'ere
Incubated at room temperature and In all other
cases, at 37°C.
For Rhesus blood factors five antisera *nti-D,
-C, -K, -c, and anti-e were used and the probable
genotype was determined from the exoected frequency
table.
Testing the serum against a panel of cells
When an antibody was detected, its specificity
could be *guessed'/
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'guessed' from the nature of its reaction (e.g.
thermal amplitude, whether active only by Coombs'
technique etc.) and from the genotypes of the
recipient's and donor's red cells. however,
the specificity of the antiserum was confirmed by
testing it against as many as possible group 0
cells some of which contained the suspected antigen
and the rest without it.
Absorption and Flutlon Techniques
In one case (Case No. 267, see later) two
antibodies ith different specificities were
detected and both of them were active at 37°C.
For isolation of these antibodies the following
procedure was used:
One ml, of washed packed cells (containing
the appropriate antigen) and 1 ml. of serum under
test were put in a test tube end capped; this was
then Incubated at 37°C. for 24 hours. The
supernatant was removed and tested for the presence
of antibody with specially selected cells to see
J whether the absorption was complete or not. The
red cells were washed three times in large volumes
of saline, previously chilled at 4°C. The last
washing was retained and tested against red cells
with corresponding antigens to show that the
washing had removed all uncombined antibody.
After the last washing, all supernatant saline
was/
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was removed, 0,5 ml, of fresh asline added and the
contents mixed by shaking, The tube was then
placed In a rater bath at 56°0« for 5 minutes and
agitated at frequent intervals. To avoid cooling^
the tube v.as spun quickly in centrifuge bucket
containing water at 56°C, The supernatant - the
eluate, »ae removed immediately and the testa . .1th





Screening tests for the detection of anti-
sbodies were carried out on the sera of 712 patient
using the test cells and methods described above.
The following antibodies were detected.
Type of antibody Number of cases








The non-specific cold agglutinins, detected
in the sera of 569 patients (approximately 79% of
all cases) were active only at 4°G. Every serum
showing a cold agglutinin, reacted with the
patient's own cells as well as with those in the
cell panel, and the reactions were reversible.
Titrations for cold agglutinins were carried out
against patient's on saline suspended cells and
in three cases the titres vere especially high as
follows:
Case Number Piagnosis litre
14 Haemolytic anaemia 1:256 i
51 Multiple myeloma 1:128
129 Chronic lymphatic leukaemia 1:128
In/
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In the remaining cases, the cold agglutinin
titres varied from 1:4 to 1:32; the higher end
points ( ithin this range) being obtained in
group A, B, and AB as compared to those in group 0
individuals.
anti-Lewis_antibodies
Of the 11 antJrLewis antibodies detected, 8
o Id
were anti-Le , 2 anti-Le snd one was a mixture
0 £)
of anti-Le and anti-Le . All these antibodies
were active at room temperature and only one serum
containing anti-Lea haemolysed trypsinised
Le(a+) cells at 37°C.
Seven of these patients with anti-Lewis
antibodies in their sera were males - two of whom
hod been transfused with blood before, while five
had no history of transfusion or injection of
blood. (h2v two of the four female patients had in¬
curred the risk of immunisation, one had been
pregnant and the other had a history of pregnancy
and previous transfusion.
Antl-P antibodies
Neither of the two male patients who had
anti-r antibodies in their sera had ever been
transfused or injected with blood. The anti¬





The anti-D antibodies were detected In the
sera of one male and one female patient both of
whom were Rh negative. The male patient had
received two pints of whole blood seven years
previously without any adverse effect. Although
the Rh type of the transfused blood had not been
recorded, it may be assumed that at least one of
the donors was Kh(D>) positive. The female
patient had never been transfused or injected with
blood and none of her two children suffered from
haernolytic disease of the newborn. Blood
samples from the children could not be obtained
but as her husband was Rh(D) positive, it may be
assumed that the pregnancy was the cause of
immunisetion in her case.
The antibodies in both instances were of the
incomplete type and were detectable by albumin,
indirect Coombs* test and enzyme treated cell
techniques. The titres obtained in pre- and
post-transfusion samples are compared in Table 71
(see later).
Post-transfusion Series
Out of the 712 cases of the pre-transfusion
series, only 359 patients received blood trsns-
:fusions during the present investigation.
Seven of these transfused patients died and 30
cases were discharged before the time for taking
the/
the post-transfusion samples were due, leaving in
all 302 patients whose sera could be examined after
transfusion and these comprise the post-transfusion
series.
A short account of the patients comprising the
post-transfusion series
The distributions of ABO groups and Rh types
of the patients in this series are shown in Table i.
The occurrence of both ABO groups and Rh
types are well in agreement with those expected
in this country. The age of the patients in this
series ranged from 5 to 82 years.
Table I






Total 255 (84$) 47 (16$) 502 100$
The cases were not specially selected
but since one of the medical wards is
associated with a haematological research
unit, a relatively high proportion of
patients suffering from blood djscrssias
has been included.
The history of previous transfusion, pregnancy
and distribution of sex of the patients in this








J 127 patients with
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133 42 16 111 | 302
i
Ths high incidence of females (200) is due
in part to the inclusion of patients from
three gynaecological wards; 127 female
patients were parous - 29 priminara and the
rest multipara as shown in Pig. 1. (P.44)
It will be seen in the above table that 155 patients
(75 male and 58 female) had no history suggestive of
immunisation prior to the present transfusion.
58 patients (27 male and 31 female) had history of
previous blood transfusions, but the amount of blood
each patient had received, could not be ascertained.
The number of, and the approximate intervals between
the transfusions In these 58 cases are shown in Pig. 2. (P.44)
"fa-
It will tie seen that 6 patients had only one
transfusion, 15 received 2 or 5 at short Intervals
while 12 received the same number butthe intervals
between them were longer. in 25 coses of
multiple transfusions (more than three) the
intervals were variable.
Present Transfusion
Altogether, during the present investigation,
915 bottles of whole blood (each bottle containing
110 ml. of ACD solution and 400 m'l. of blood) and
58 bottles of packed cells were transfused. The
duration of storage of whole blood before trans-
:fusion varied from the date of collection to 21
days. The maximum amount of blood given to a
single patient was 17 bottles, while the majority
of the patients received 2 to 4 bottles of blood
as shown in Fig. 3. (P.44)
14 cases received 2 to 3 transfusions at
intervals of 1 or 2 days and their blood samples
| were obtained on the 10th to the 14th day follow-
'
:ing the last transfusion. Several transfusions
/ere given to three patients of aplastic anaemia
at intervals of 3 to 4 months. Although the
sera of these three patients were tested after
every transfusion, (3 or 4 times during this
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Fig. 2. Approximate Intervals between transfusions In 96 cases.
Each dot Indicates a transfusion. Present transfusions are represented on the tcro
x: patients showing Immune antibodies ki their sera after the present transfusion.
Fig.2, shows the number of and intervals between
previous transfusions. Transfusions during








NUMBER OF BOTTLES OF BLOOD TRANSFUSED.
Fig.3, shows the number of bottles of blood trans¬
fused to 302 patients during the present
investigation.
-h5"
There ere symptoms and signs suggestive of
haemolytic reactions as a result of the present
transfusion in three cases, but in the serum of
only one of these patients could an immune antibody
be detected (Case 281 - see later).
Six immune antibodies which could not be
found in the pre-transfusion samples, were detected
in each of six patient's serum during the screening
of 502 post-transfusion samples. These are shown
in Table III. (P.46)
Case 5.
A woman aged 45, was admitted to the gynae¬
cological ward with menorrhagia. She had four
normal pregnancies but had never been transfused
or injected with blood. On examination, her
haemoglobin was found to be 7.4 gm.$ and two
bottles of whole blood were transfused, followed
three days lster by a further two bottles. No
obvious ill-effects were observed after transfusion.
In the pre-transfusion sample no antibody was
detected; neither was there any difficulty in the
cross matching test.
Preliminary screening of the post-transfusion
sample (10th day folio-ing the last transfusion)
shoved agglutination with standard cell No. 2
(Table IV) by Coombs' technique only. (The test
was repeated at a later date with papain treated
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able I£I. iyp® of immoie antibodies deteoted for the first time in the po3t-transfusion specimens of six patients
with a snort history in each case.
Antibody in parenthesis indicates that it was detected in pre-transfusion sample.
"husband of this patient was hell-negative.
Standard test oells
Case io. 3 Case do.14 Case .0.152 Case o.211 Cu3e .40.267 Case io.281
a A IC T P o A IC T P d A IC T F J A IC T ? 5 A IC T P S a IC *T P
Mo.l. D, (CDe/CDe), JUS, P, Ick, Le (a-b+), Fy(a-) - + + + + + + + J- + - + + +■ +
fo.3. 0, rr (cde/cde), j.£s, P, kk, Le (a-b+), fy(a+) - + + + + - - + - + + + + + + - - + - + - . 4 - 4
Table IV, 5, a, IC, T, and P indicate saline, albu.iin, indirect Coonbs1, trypsin and pupaiu iot..ods respectively.
+ "Agglutination
- s=i do agglutination
Test with papain treated ceLls was lone later using the frozen seru..
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stored at -2C°G., and the result was positive).
The blood groups and genotypes of the patient,
husband and four donors and the reaction of her
serum with donors' cells (by Coombs' method) are
shown below.
Genotype
Patient 0, CBe/ode, IDT, kk, Le(a-h+), Fy(a+)
Husband A, CDe/CDe, N, kk. Le(a-h-), Py(a+)
Donors 1. 0, CDe/cde. MN, kk. Le(a-b-), PV(a-)
2. 0, CDe/cde, N, K, Le(a-b+), BV(a+)
3. 0, CDe/CDe, MN. kk, Le(a-b+), JV(a+)
k- 0, CDe/cde, M, kk, Le(a+b-), FV(a+)
Reaction with patient's serum





It was found that the patient's serum
agglutinated the red cells of donor 2. Prom the
genotypes and the reactions of the patient's serum
vsith standard cells and donor's erythrocytes, it
appeared that the antibody was anti-Kell.
For confirmation, 10 group 0, Kell-negative
and 4 group 0, Kell-pcsitive cells were tested
against patient's serum by indirect Coombs'
method and the reactions are shown below.
Red cells Reactions with Patient's serum
Positive Negative
hell-positive 4 0 4




The'exact' probability of the antibody being
anti-Kell = 1,001 to 1.
xhe titre against standard cell number 2. by-
indirect Ccombs' method was 1:32.
Case 14.
An unmarried woman, aged 28, was admitted to
the medical ward as a case of haemolytic anaemia
with 6.5 gm.$ haemoglobin. 9 months prior to the
present admission, she had a transfusion of two
bottles of group 0, D-positive blood without any
apparent ill effect.
On admission, a direct Coombs' test on her
red cells was negative: no Immune antibody could
be demonstrated in her serum but the non-specific
cold agglutinin titre was high (1:256). Five
bottles of blood were transfused and there was no
untoward effect.
On the 13th day following the present trans-
:fusion, her serum was found to agglutinate all
three standard cells (Table IV) as well as her own
cells, by the albumin, indirect Coombs', trypsin
and papain methods. The direct Coombs' test was
now found to be positive. It was noted that
reactions against standard cell Nos. 1 and 3 were
much stronger than that with No. 2. The geno-
:type of the patient was -
0, CDe/cde, MN, kk, Le(cH-b-), Fy(a+).
From/
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From the reactions of the serum with the
standard cells it appeared that the antibody might
be anti-e, shoeing a 'dosage effect'.
The titres of this antibody against e/e and
B/e colls by different methods were as follows:
Cells Albumin indirect Trypsin Papain
method Coombs' method method method
e/K 1:4 1:32 1:16 1:64
e/e 1:8 1:128 1:128 1:512
The specificity of the antibody was confirmed
by testing the sera against a panel of 53 group 0
cells, ten of which were Kh-negative (cde/cde; and
43 were Rh(D)positive. All the Rh-negative and
41 Rh-positive bloods were agglutinatted by the sers.
The two Rh-posltiv© bloods vhich gave negative
reactions were cDa/oDB.
Note:
This is a. case of auto-immunisation because
the patient herself was 'e' positive. The
negrtlve result on the pre-transfusion sample may
probably be due to the quiescent stage of the
disease at that period of examination.
Case 152
A man aged 20, suffering from cholecystitis,
was admitted to the surgical ;ard for operation,




Anti-Les antibody was found in the pre-
transfusion sample but no immune antibody could be
detected.
On the 11th day following the transfusion of
three pints of group A, D-positive blood an
antibody was detected in his serum which reacted
against standard cell Nos. 2 and 3 (Table IV) by
indirect Coombs1 and papain methods. The patient
genotype was -
A, CDe/CDe, N, K., Le(a-b-), Fy(a+).
From these reactions against the standard cells
and the genotype of the patient, it was suspected
that the antibody might be anti-c or anti-s. On
testing the sera against c-positive but s-negative
cells a positive reaction was obtained. The
specificity of the antibody anti-c was further
confirmed by testing the serum against 7 o-positive
(4,c/c and 3,C/c) and & c-negative (C/C) cells
with the following results:
Red cells Reactions with patient's serum
Positive Negative
c-nositlve 7 0 7
c-negative 0 5 5
7 5 12
'Exact* probability = 792 to 1.
Naturally occurring anti-LeB did not interfere
with the tests, as it did not show any reaction at
37°C., (although it was active at room temperature|) .
On/
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On the 26th day following the transfusion,
another fresh sample was tested but no appreciable
change in the antibody titre was observed; the
results of titrations on both days are shown below
By indirect By papain
Coombs' method method
Titre on 11th day
following transfusion 1:32 1:128
Titre of 26th day
following transfusion 1:32 1:64
Case 211
A man aged 65, was admitted to the surgical
ward with hsemstemesis, and subsequently diagnosed
as a case of perforated peptic ulcer. He had had
a transfusion of two bottles of blood about 5 years
ago without any adverse effect. On admission, no
antibody could be detected in the pre-transfusion
sample. During the operation, 5 bottles of group 0,
D-oositlve blood were transfused followed five day
later by another two bottles
On the 10th day following the last transfusio
his serum agglutinated standard cell aos. 1 and 3
by all the methods used as shown in Table IV.
Patient's genotype was - 0, CDe/CDe, N, kk,
Le(a-b-), Fy(a+).
From the reactions against the standard cells
it appeared that the antibody was either anti-P or




but Le^-nagative cells and no agglutination was
observed. Blood samples from three of the donors
(of present transfusionJ were available end tested
against patient's post-transfusion serum. The
results are shown below.
Donor Genotype Reaction with patient's (jerur,
1. 0, CDe/cde, MN, kk Le(a-b+L Fy'.a-' Fositive
2. 0, CDe/ode, N, kk Le(a-b+), JV(a+; Positive
3- 0, CDe/CDe, N, kk Le(a-h-), Fy(a+; Negative
The pest transfusion sample agglutinated the
cells of donors 1 and 2.
Finally the serum was tested against 15 group
cells with known Lewis group and the results were
as follows:




Le(a-bf ) 5 0




The specificity of the antibody as anti-Le^
was thus confirmed.
The titres of the antibody against group 0.
Le(s-b+; cells by different methods were se follow
Saline Albumin Indirect Coombs' Trypsin Papain
1:8 1:16 1:64 1:32 1:64
Case 267
A 30 year old man, suffering from peptic
ulcer was admitted to the surgical ward for
gastrectomy. He had had a transfusion of 2 bottl
of blood 7 years previously and in his pre-trans-
:fusion sample (in relation to the present trans¬
fusion) anti-D antibody was detected. This cas
has already been referred to, in the pre-trans-
:fusion series.
During operation, 3 bottles of group A,
D-negetive hole blood vere transfused and there
was no adverse reaction. On the 12th day follow
:ing the present transfusion, an additional immun
antibody was demonstrated in the patient's serum
in addition to the rising of anti-D titre (see
later}. The patient's serum agglutinated standa
cell Nos. 1 and 2 by albumin, indirect Coombs',
trypsin and papain method end Mo. 3 by indirect
Coombs* and papain methods (see Table IV). The
genotype of the patient was - A, cde/cde, MN, kk,
Le(a-b+), Fy(a-), Blood samples from two of the
donors (of the present transfusion) were
obtained/
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obtained and tested against patient's serum with
the following results:
Genotype Heaction with patient's serum
A, ode/ode, II, kk, , ^(a-. Negative
A, ode/ode, N, kk, I*(a-b+\ jy(a+) ?osltive
The patient's serum agglutinated the cells of
donor 2. Prom the nature of these reactions it
aDPeared that the new antibody was anti-Fy .
The antibody was absorbed by treating the
serum with D-negative, Pya-positive group 0 cells
and finally eluted. The eluate was tested with
7 Fya-positive and 4 Fys-negative group U cells by
indirect Coombs' and Papain methods and all the
FyS-positive cells were found to be agglutinated
while no reaction was observed with any of the
Fya-negative cells.
Case 281
a married woman aged 49, was admitted to the
surgical ward with appendicitis. She had six
pregnancies and between the third and fourth a
miscarriage. She had a transfusion of two






previously and there was no reaction.
On admission, no antibody could be detected
in her serum. During the operation, four bottles
of group 0, D-negstive blood were transfused and
a few hours after comoletion of the transfusion she
complained of feeling cold and had a slight rigor.
The folio ing morning she passed reddish brown
urine fthich contained urobilin; the serum bili¬
rubin content was 5 mg.%. Her condition settled
within 24 hours and recovery was uneventful.
The compatibility test was repeated with the
pre-transfusion serum and was still found to be
negative, neither could any antibody be demonstrated
in the immediate post-transfusion sample.
On the 10 day following the present trans-
sfusion, her serum agglutinated the standard cell
Mo. 3 (Table IV) at first by the papain method
only. The indirect Coombs' test was repeated but
the result was negative. Using different





Dil.utions o.1r Coombs' serum
1/2 1/4 1/8 1/16 1/32 1/64 1/128
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The/
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'i'he genotype of the patient was - 0, cde/cde,
MN, K, Le(a+b-), Fy(a-).
Prom the patient's genotype and the reaction
of her serum with the standard cells It appeared
that the antibody might be anti-Fya. The
soecificity of the anti-serum was confirmed by
testing it against 7 Fya-positive and 6 Fya-negative
group 0 cells with the following results:
Red cells Reactions with patient's serum
Positive Negative
Fy(a+) 7 0 7
Fy(a-) 0 6 6
7 6 13
'Kxsct' probability = 1716 to 1.
Note:
It has been found in this case that the
dilution of Coombs' serum optimum for the detection
of Rh-antibodies is not the same as for anti-Fya.
Kffect of blood transfusion on the antibodies
detected in patient's sera prior to the present
transfusion
277 patients with non-specific cold agglutinins
in their sera (detected in the pre-transfus ion
samples; received blood tranfusion during the
present investigation. In only one case (No. 14,
Table III, a case of haemolytic anaemia) was there
a rise in cold agglutinin titre in the post-trans-
sfusion sample. The titre in this instance, rose
to /
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to 1:1024 from its pre-transfusion level of 1:256.
Seven out of 11 patients who had anti-Lewis
antibodies in their sera, were transfused, six
with one or two bottles of Lewis incompatible
and one with one bottle of Lewis compatible blood.
The Lewis blood groups of these 7 patients
and those of their donors are shown in Table V in
which anti-Lewis lso-sgglutinin titres of pre-
and post-transfusion samples have been compared.
It will be seen that there was no appreciable
change in titres after the transfusion. It was
also observed that there was no change in thermal
amplitude of these agglutinins and there was no
reaction in any of these cases following trans-
:fusion.
Table V - (page 59).
Antl-D
Two bottles of D-negative blood were trans-
:fused to each of the two patients shoeing anti-D
antibodies in pre-transfusion samples. One of
these cases (Case 267, Table III) developed anti-
Fya as a result of present transfusion and has
already been described. In both cases a rise in
Bnti-D titre In post transfusion samples was ob-
:served and this is shown in Table VI (page 59).
It/
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It was thought that this rise of antibody
titres might be due to weakly reacting D antigen
and therefore all four donors' cells were tested
for Du by indirect Coombs' method, but all of them
were found to be Du-negative.
In 148 cases including case No.152 (Tnble(III)
it was possible to obtain samples again on or
about the 4th week following transfusions.
No antibody other than those found in previous
examinations, was detected, nor was there any
change in titre of antl-c antibody (in Case 152).
Table V/
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Table 7. The effects of transfusions of compatible and
incompatible blood (of Lewis group) on the
naturally occurring anti-Lewis antibodies.
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Table VI. The effects of transfusion of D-negative blood
on anti-D titres in two cases who were
previously immunised.


























"ntlgenlclty of different blood factors and their
role In Iso-immunisation
Advances made by several workers during the
last few years in the methods of detection of iso-
antibodies and their application to the study of
iso-immunisation have led to a great development
in blood group serology. Iso-immunisation as a
result of blood transfusion, may occur if the
transfused blood contains an antigen which the
recipient lacks. haemolytic transfusion reactions
may be avoided by proper cross matching tests but
the methods used at present are not sufficient to
I prevent Iso-immunisation due to one or other of
the new blood factors. As there are no corres-
:ponding natural antibodies against the majority
of these antigens blood which appears to be suit¬
able may not be homologous with regard to 8ll
these new blood factors. Thus, it is evident
that the incidence of iso-immunisation against
certain blood factors (which are not at present
routinely screened in the cross matching test)
will steadily rise with the increasing number of
transfusions. If immunisation occurs against a
common or multiple blood factors, there will be
difficulty In obtaining suitable blood if required
for/
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for such recipients In the future. Moreover,
Iso-immunisation of female patients In this way
before or during the childbearing period may cause
haemolytio disease of the newborn in any future
pregnancy.
Under these circumstances, It would be desire-
:able to prevent such immunisation entirely, but
this could only be acnieved by giving "exactly"
homologous blood, which is impracticable due to
multiplicity of blood group antigens. Fortunately
however, all the blood factors are not equally
antigenic and a selection can be made. For this
-
purpose it is necessary to know which are the more
antigenic ones ana the actual risk involved if a
particular antigen is not screened.
The most reliable method of determining the
antigenicity of a blood factor is the experimental
immunisation of human volunteers or clinically the
antigenicity may be assessed from the relative
proportions of different blood group antibodies
which occur as a result of incompatible trsns-
:fusion and/or pregnancy.
The present status of our knowledge about
the main blood group systems is well explained in






















ABO Regular Yes I common) Yes (mild form
common
Rh Extremely rare Yes (common) Yes (common)
MNS Rare Yes (rare) Yes (very rare)
P Occasional Yes (very
rare)
No
Lutheran Extremely rare Yes (very
rare)
No
Kell Not yet described Yes
(occasional)
Yes (very rare)
Lewis Occasional Yes (rare) No
Duffy Extremely rare Yes (rare) Doubtful
Kidd Not yet described Yes (very
rare)
Doubtful
On the clinical and experimental evidence, all the
factors of the nine main blood group systems may be
classified into two broad divisions -
(1) those which give rise to iso-immunisation more
readily e.g. A and B antigens of the ABO groups
and D antigen of the Rh system.
(2) those which give rise to iso-immunisation less
frequently e.g. C,E,c,d,e and f antigens of the
Rh system and all the antigens of MNS,P,Lutheran,
Kell, Lewis, Duffy and Kidd systems.
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Blood factors giving rise to Iso-lmmunlsatlon
more readily
ABO system: The ABO groups sre by far the most
dangerous in blood transfusion practice, because
of the constant presence of natural iso-sgglutininii
in this system. The method of detection and pre¬
vention of complications due to ABO blood groups
is however relatively simple and because of this,
difficulties should not arise except from clerical
and technical errors. Where ABO incompatible
blood has inadvertently been transfused, it has
been reported ('lhalhimer, 1921; Wiener, 1941;
Mollison and Young,1941; Boorman, Dodd and
■
Mollison,1945; Wallace,1950) that there was a
rise of iso-agglutinin titres in every case and
the immune characteristics of the lso-agglutinins
in s\ich cases have been demonstrated. It has
j a 1so been noticed by some of the authors (Wiener,
1941; Mollison and Young,1941; Wallace,1950)
that there may be an initial fall in the titre
immediately after an incompatible transfusion
folio ed by a steady rise reaching a peak some
time during the second week, Hsemolytic disease
of the newborn, though of milder degree* may also
occur due to ABO incompatibility. These observ¬
ations suggest that A and B factors of the ABO
system act as strong antigens. Vihether this
action/
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action is due to strong antigenicity of these
factors or due to previous stimulation of the
recipients against these group specific substances
is not known. However the current reports
(Hubinont,195C; Aiener,1951a) suggest that iso-
agglutinins occur as a consequence of immunisation
with blood group A and B substances, which are
widely distributed in nature so that contact with
them as they occur in foods, inhaled materials,
danders, dusts, micro-organisms etc., is almost
universal.
D antigen of the Kh system: It is not usual for
naturally occurring Rh antibodies to be present
in human sera (although occasionally reported e.g.
anti-D by Grove-Rasmussen and Levine,1954; anti-B
by Stratton,1953 snd Race and Sanger,1954). So
the detection and prevention of immunisation
against Rh factors are rather complicated. With
the wide application of screening of the D antigen
during recent years, sensitization against this
antigen, as a result of blood transfusion, has
considerably diminished (and no case of such
sensltisation as a result of transfusion during
the present investigation, was detected). How-
sever, sufficient information about the antigenicity
of the D factor may be obtained from the many
reports published in the literature since its
! discovery/.
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dlscovery. Although the clinical importance of
the Rh(D) factor was realised just after its
discovery, precautions against transfusion of
D-positive blood to D-negative persons could not
be undertaken immediately, because anti-hh (anti-D)
sera were not easily available and moreover, the
Blood Transfusion Services were not so well
organised at that time. As a result, during the
earlier days, even after the discovery of Rh(D)
factor, there were a certain number of cases of
Rh(D) incompatible blood transfusions. Reports
have appeared on retrospective examinations of
some of these cases. At first there was no
agreement among the various workers about the
incidence of sensitization due to D-antigen.
Wiener(1945a, 1945b, 1946a) stated that between
1 in 50 and 1 in 25 Rh-negative persons who sre
exposed to Rh(D) antigens become immunised. He
further stated that the incidence of sensitization
due to Rh-positive pregnancy and by transfusion is
about the same. Unger(1946) observed that when
repeated transfusions of the Rh-positive blood are
given to Rh-negetive patients the response to the
Rh(D) antigen develops in approximately 1 in 25
patients. DeGwin(1945) in a series of 5,586
consequtive blood transfusions, found that 6.6$
of the Rh-negative patients were immunised against
Rh(D) factor/.
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Hh(D) factor. DIamond(l946) on the other hand,
demonstrated antl-D antibodies in 50$' of the
Rh-neg8tlve individuals in a series of 2,500 service
:men who had transfusions under war-time conditions
without regard to Rh type. Ross (quoted by
Hsttersley,1947) in a smaller series found sntl-D
antibodies In nearly 50$ of Rh-negative bloods.
In a similar survey, Hattersley(1947) examined the
blood of groups of servicemen who had at some time
in the past received transfusions presumably with-
:out the benefit of Rh typing, and he found 55$
of the Rh-negative people immunised. Pickles in
an unpublished observation, cited by Mollison(1956,
demonstrated anti-D antibody in 50$ of the Rh-
negative individuals after a single transfusion.
The dlscrepencies in these results may be explained
by the fact that In some of the earlier investig¬
ations, methods for detection of Incomplete
antibodies had not been included.
In immunisation following pregnancy, the D
antigen is responsible for approximately 90$ of
cases of haemolytic disease of the newborn.
In addition to the above findings about the
antigenicity of the D factor, further evidence may
be accumulated from the work of several authors
(Diamond,1944b, Hill and his associates,1945,
Gold and Turcanu, 1947, Wiener ,1949) who carried
out/
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out experiments by Injecting smell amounts of
D-positive blood into D-negative volunteers.
Different authors adopted different courses of
injections and found that individuals vary widely
in responding to antibody formation. In review-
:ing the results of experimental immunisation
against D antigen, Mollison(1951) concluded that
"in order to provoke the formation of antl-Rh with
the least possible number of injections an interva
of four months should be left between the first am
second injection; ten days after the second injec
:ion almost 40% of the subjects may be expected to
produce antibody". The results of the present
study support this observation (c.f. Ceses2Ll, 267
and 281, Table III).
experimental immunisation cannot be compared
directly with sensitization as a result of routine
blood transfusion because, (1) the condition or
disease for which patients are admitted to hos-
:pital may influence the result (c.f. Case 14,
Table III), (2) the intervals between the inject¬
ions of blood Into volunteers can be controlled,
(b) the amount and age of the blood can also be
controlled according to the need In case of
voluntary Immunisation whereas in routine trans-
iftislons this Is not practicable. However, It
may be concluded from the above clinical and ex¬
perimental/
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experimental findings that aprroximstely 50'■ of
the people may produce antl-D after a single trans-
sfusion end it has generally been accepted that in
addition to ABO groups, the D antigen of the Rh
system must be considered in ell cross matching
tests.
Blood factors giving rise to iso-Immunisation
less frequently
While the import nee of antigenicity of D
factor has been established beyond doubt, no
definite conclusions have been reached about the
relative antigenicity of the other factors of the
Eh system and other nev, blocd factors. Originally
it was thought that sensitization due to these so-
called 'less antigenic• factors was very rare and
lener(1954l stated that sensitization due to 0,
tf, c, e, Fy, K, S etc., are the nature of 'medical
curiosities'. Following the publications of
numerous reports on esses of iso-Immunisation
against these blood factors by several orkers
during recent years, it h"s been found that these
ant I ens are not so 'weak* as they were originally
thought to be. In a series resulting mainly from
transfusions Spelser end Kolbl(195W detected 9fc
cases with anti-D antibodies and 40 with antibodies
other than pure anti-D. In similar series of
Vogel(1954J and that of Kellner(19551 the pro¬
portion/
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proportion of pure antl-D to antisera other than
pure anti-D (excluding anti-A, -B, -0 or -H, un-
:identified antibodies, high titre cold agglutinins
and panagglutinins) was 95:105 and 24:37 respective-
:ly. These latter antibodies included anti-G, -
(in addition to anti-D+anti-G and anti-D+anti-E),
-Cw, -c, -e, -K, -Eya, -Fyb, -Jka, -M, -N, -S,
-Lea, -Leb and anti~P. Levine et. al(1956) in
reviewing the results of these series and comparing
T
them with that of their own (a series comprised of
oartially selected samples) stated that ©nti-c,
ant.i-ii and anti-Kell can no longer be considered
rare antibodies. As for anti-Kell this is con-
■
:firmed by the findings of Grove-Rasmussen et si.
(1954) and Bo ley(1955; who reported 36 and 28
cases respectively during the last fe years.
Malone and Dunsford (1951) reported 12 cases of
pure nnti-E as a result of pregnancy 8nd transfusion.
Anti-c sera is rather a common finding and it is
one of the four main Rh antibodies tnat are used
in routine genotyping. However, Levine and his
associates (1956) found 177 atypical antibodies
(other than antl-D, -GD and anti-DE) and 43 of
them were anti-c.. The antigenicity of C and E
in relation to D factor may be understood from
the observations of Race (MRG Memo., No.27) that
most Kh-positive bloods belong to CDe/cde or
CDe/CDe,/
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CDe/CDe, but those individuals of type cde/cde who
form anti-Rh 60% form anti-D, and sntl-D+anti-G
occurs together in about 50% of all anti-Rh sera
and anti-D+anti-K in about 2%
A limited number of investigations have been
carried out to immunise volunteers against bjood
factors other than D. Van Loghem(1947) was able
to produce anti-G and anti-s; without anti-D in
Rh-negative (cde/cde) volunteers by repeated in¬
fections of Cde/cde and cda/cde cells respectively.
Jones et al.(1954) tried to produce antl-G and
anti-E in suitable Rh-positive recipients by
giving injections every third week, but amongst
a totrl of 32 volunteers injected over a period,
of one and a half years not one produced the de~
:sired antibody. On the other hand Johns et al.
(1954) succeeded in producing anti-c in 2 out of
9 volunteers who were given repeated injections
of c-positive blood over a period of 10 months,
l'hese authors also gave e-positive blood to a
volunteer of the probable genotype cDk/cDE;
after six years anti-e was found for the first
time. Van Loghem and his ossociates(1953)
rinto/; out that the order of antigenicity within
the Rh system to be D>k>G and d*. ec c. Race
and Sanger(1954) attempted to immunise volunteers
against a number of blood group antigens. Most
of/
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of the volunteers were given 4 injections of 1 ml.
of blood at 3 months intervals; none of them
produced antibody and these results are given
below.
21 MS/MS volunteers failed to produce anti-s
34 CDe/cDifi volunteers failed to produce anti-d
18 candidates failed to produce anti-Fya
13 candidates failed to produce anti-Fy^
16 candidates failed to produce antl-Jka
12 candidates failed to produce anti-JkD
From the above findings it can be stated that
though volunteers are immunised with difficulty by
injection of these 'less antigenic' blood factors,
sensitization due to these antigens as a result of
blood transfusion is not rare. Although the
antibodies against most of these factors have been
found to give rise to haemolytic transfusion
reaction and/or hsemolytic disease of the newborn,
only the C and a antigens (in addition to D
antigen of the Rh system) are screened in the
cross matching tests at present and that only in
selected cases viz. when the recipients are Rh-
negatlve. This procedure of screening of C and
antigens only partially prevents the possible
immunisation against these antigens since in D-
positive recipients these antigens are not
routinely checked and therefore, for example,
CDe/CDe/
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CDe/CDe end ODe/cde recipients may be transfused
with cDa/cDis or cDis/cde blood or vice versa and
ariti-Jts or anti-G may be developed as the case may
be. Thus some of the R5$ of the D-positive
population are exposed to the risk of immunisetion
against these antigens. Surprisingly enough, no
anti-C or anti-is was found in the present invest¬
igation. It seems from the present observation
as well as from that of Van Loghem(1947) and Jones
et al.(1954) (stated above) that Rh-negative
persons (cde/cde) are more prone to form anti-C
and anti-e, than suitable Rh-positive persons.
ttxpected Incidence
The most reliable method for determination
of the incidence of iso-immunisation due to blood
group antigens which are not at present routinely
screened, would be to genotype fully the donors*
and recipients' cells. The exact rate of
•incompatible' transfusions in relation to various
blood factors would then be known, and then the
recipient's sera be examined to detect complete
and incomplete antibodies after an appropriate
interval. This procedure unfortunately, is not
at present practicable. Alternatively, by
making use of the following gene frequency table
(Race and Sanger 1954) the chances of incompatible






































If for example, the D factor of the Rh-
system is not taken Into account in the compat-
:ibillty test, the incidence,in all transfusions
given,of D-negative people getting D-positive bloo3
may be calculated thus:
(Frequency/
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(Frequenoy of dd) x frequency of gene D, or
(0.41)^ x 0.59 - 10% (approximately).
If iso-immunisation would occur in every case
of incompatible transfusion, its incidence due to
various factors could be calculated in a similar
way and it would be approximately as follows:
0-13$, £-11$, c-10$, d-14$, e-2.5$, K-4.5$,
k-0.2$, Fya-14$, Fyb-10$, M-12$, N-13$, S-15$,
s-7$, Lua-4$, Lub-0.2$, Jka-12.5$, Jkb-12.5$.
The above calculated values of the incidence
of iso-immunisation are based on the transfusion
from a single donor and the incidence will be pro¬
portionately high with the number of donors used
for each recipient.
Observed Incidence
In the present study an attenpt was made to
detect all possible cases of immunisation due to
C,c,D,d,js,e,M,N,S,s,P,K,k,Fya,Lea and Leb blood
factors and therefore test cells containing all
these antigens were used during the whole invest¬
igation. in the limited series of 302 post¬
transfusion samples, one example each of anti-c,
-e, -K, and snti-Leb and two of antl-Fy8 have been
found and none of these antibodies could be
detected in the pre-transfvision samples of the
recipients.
If it is assumed that all the blood factors
are/
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are eqitally antigenic and using the established
fact that 50$ of the D-negative individuals become
sensitised, (thus 50$ people being susceptible) one
could expect that sensitization due to other blood
factors would occur in approximately 50$ of the
calculated values (this will be more if the
patient is transfused with blood from more than
one donor, and the risk due to pregnancy is con¬
sidered). However, the observed incidence is
far below the figure that could be theoretically
expected. This difference between the observed
and expected incidence can not be explained by
the weakness of the antigens, because in sus-
rceotible persons a single transfusion may produce
antibodies against so-called 'weak* antigens.
This fact has been observed in the present study;
two patients (Gases 3 and 152) developed nnti-K
and anti-c respectively due to the oresent trans-
:fusion and neither of them had any previous
history, suggestive of immunisation. On the
other hand, there were three cases of aplastic
anaemia who had multiple transfusions (an 'ideal
condition' for the development of antibodies) but
none of them produced any antibody.
Thus it appears that some other factors may
possibly be responsible for these discrepencies





(1) Those suggested by various workers e.g.
(a) Heriditary (Hirszfeld, 1926) or
K-faotor (hiener,1946b).
(b) Nutritional (Cannon et al.1943).
(c) Hormonal and nutritional (Unger
and Wiener ,1945) .
(2) That appropriate administration of an
antigen in embryonic life results in an
acquired specific tolerance to that
antigen so that in later life the
individual will not produce antibody to
it. In favour of this view are the facts
that -
(a) Buxton(1954), and Horowitz and Oven
(1954) were able to induce specific tolerance to
antigen by injecting it in animals at a particular
stage of embryonic life.
(b) In relation to the question of why
only some of the v omen of Kh-negstive type who
produce Rh-positive offsoring are immunised by the
D antigen, Owen et al.(1954) in an examination of
serolo leal data found that the Rh status of the
woman's mother was significant. Rh-negative
women who were married to Rh-poeitive husbands
and had experienced three pregnancies were divided
into/
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into those who had Rh-po3ltive and Rh-negative
mothers. Amongst 29 who had Rh-positlve mothers,
25 had not produced antibody (86%), while 22 with
Rh-negative mothers only 9 had failed to produce
antibody (41$). The difference is significant
and suggests that many of the first group had been
conditioned to tolerate D antigen by exposure to
it in utero.
(5) That the results of the present study may
not be a true representation of the
incidence of iso-immunisation as a
result of transfusion because,
(a) The time of appearance of immune
antibodies is variable and in some patients there
may be a considerable delay before agglutinins
become evident. As a general rule, antibodies
develop during the second week following the
antigenic stimuli, but Pickles (cited by Mollison,
1956) observed that the best time for examination
of the sera for the presence of antibody was 20
weeks after transfusion. However in approximately
half of the cases in the present series, post¬
transfusion samples were examined for the 3econd
time on the fourth week following transfusion but
no antibody was detected which could not be found
in the earlier examination of the post-transfusion
samples (on tne second week).
(b)/
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(b) It Is doubtful whether all the anti-
:bodies can be detected by methods used at present
In three cases, symptoms and signs, suggestive of
haemolytic reactions developed following blood
transfusion during the present investigation but
no antibody could be detected in the sera of two
of these cases even on repeated examinations.
Ho ever, the post-transfusion samples in these
cases could not be tested against fresh donors'
cells and that may be the cause of failure in
detection of any antibody (see part II).
The third case (no. 281, Table Hi) develop¬
ing a haemolytic reaction, had a transfusion of
blood three years back and although no antibody
could be detected in her pre-transfusion serum
(in relation to the present transfusion) it is
obvious that the antibody developed as a result
of previous transfusion (in view of the haemolytic
reaction due to present transfusion) and the
antibody being in a "latent state" could not be
detected by the methods used.
Although the Incidence of iso-Immunisation
(with regard to blood factors that could be
included in the test panel) in the present series
is muoh less then what could be theoretically
expected, it is higher than most of the results
obtained by different workers during routine blood
bank/
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bank work dealing with investigations on transfusion
reaction and cross matching difficulties.
Ho ever, in an investigation similar to the
present one, Csllender and Paykoc(1946) examined
the post-transfusion samples 10 to 14 days follow¬
ing transfusion in 100 patients and found that
two persons were sensitized. One of them was
Rh-negative and was immunised against D factor
: while the other was Rh-positive and was immunised
against several blood factors. This is an in¬
cidence of 1% immunisation against blood factors
other than D, but thi.s would only be found if the
blood samples are examined in each case after
routine transfusion. These authors could not
apoly Coombs' test in their investigation, and in
that case it may be expected that the incidence
would be higher.
Kilduffa and DcBakey(1942J compiled the
results of 43,294 blood transfusions by 18
different groups of workers. There were 1.8
haemoli'tic reactions in every 1000 transfusions.
Speiser and Kolbl(1952) found atypical antibodies
(including anti-D, -CD, -T?D) in the sera of 132
Individuals resulting mainly from transfusion
during 1948-51 (the number of cases investigated
not mentioned). Kellner(1955) detected 76 cases
of iso-immunisation due to various blood factors
in/
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In a series of 14,755 consequtive blood transfusions.
More recently, lallace(1956) reported 13 immune
antibodies specific for antigens other than A, B
and Rh(D) in a series of 13,000 recipients.
Most of these results cannot be compared with
that of the present study because (1) the incidence
of haemolytic transfusion reaction is not the same
as that of iso-immunisation, since every case of
immunisation may not necessarily give rise to
transfusion reaction. (2) in some of the series,
the samples were partially selected and included
cases of sensitization due to pregnancy. However,
if these results are analysed and only the blood
factors against which antibodies were expected to
be found in the post-transfusion samples of the
present series (i.e. blood faotors contained in
the standard cells excluding the D antigen) are
taken into account, the Incidence of iso-immunls-
:ation will be 0.1 to 0.2 per cent. On this
basis, in the present material of 302 post-
transfusion samples, six asea of iso-immuni3ation
j were detected - an incidence of 2% - which is
significantly higher than those reported above,
and this observation indicates that much higher
incidence would be obtained if post-transfusion
samples are examined systematically rather than
In response to a specific indication (e.g.
reaction/
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reaction or technical difficulty during compat-
tibility testing).
Of these six cases, case 14 (Table III),
whose serum contained anti-e, suffered from auto¬
immune haemolytic anaemia while in the remaining
five, sensitisation occurred as a result of
transfusions. In two of the latter cases (Nos.
3 and 152) the present stimulation aopeared to be
the sole cause of immunisation because, one of
them a male patient, had never been transfused
and the other a female patient, who developed
anti-K antibody, had no history of previous trans-
:fusion and although she was parous, her husband
.
was Kell-negative. The remaining three cases
(Nos. 211, 267, and 281) had previous transfusions
which may have produced susceptibility to Imuran-
:isation without producing detectable antibodies
(which may be the probable explanation of not
finding any antibody in their pre-transfusion
samples).
The relation of Immunisation in these six
cases to previous transfusions end/or pregnarcy




































2 2 (1) 0 1 6
The figure In parenthesis indicates case 14.
(auto-immunisation)
It should he noted that these six cases do
not include case 271., who developed anti-D
as a result of pregnancy. This case is
discussed under anamnestic reaction
(see later).
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If the occurrence of isc-Immunisation Is
compared among the patients with a previous
history of pregnancy and/or- transfusions and
among those without such history, it will he
found that three out of 169 of the former group
(1.8$) and two cut of 133 of the latter group
(1.5$) were immunised. This difference is not
of much significance and it is of interest to note
that the majority of the former group consisted of
women with history of pregnancy alone. If however,
one compares the incidence among those who had
previous transfusion and those who had not, it
will be found that three (5$) (excluding case 14)
of the 58 previously transfused patients (Includ¬
ing 16 who had pregnancy also) and to (G.8$) of
the 244 patients who had no history of transfusion
were Immunised. These results are shown in the
following table.
Cases with no Cases with history












3uch a difference Is highly significant and
oonfirms the previously established fact that the
incidence of immunisation will be much higher
among the previously transfused patients than
among those who had never been transfused. This
observation in particular, is of importance because
the number of hospital-admission of patients for
whom blood is requisitioned more than once, is
constantly increasing - a fact vdiich is emphasised
by the present observarion that 58 {approximately
20#) of the total 502 patients, actually trans-
:fused, had received blood at a previous admission.
The above findings also support the observat¬
ion of Mollison (MRC Memo., No.27) that transfusion
is a better stimulus than pregnancy.
Although it was noticed that iso-immunisation
occurs more commonly among previously transfused
patients, it is of interest that the present study
does not confirm the common belief that patients
receiving multiple spaced transfusIons are more
prone to be immunised. Of the 58 previously
transfused patients six had only one previous
transfusion and four of them .ere sensitized (see
fig.2) and contrary to the expectation, no anti-
:body could be detected in the sera of the remain¬
ing 52 patients although all of them had more
than one transfusion and several had multiple
(more/
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(more than three) spaced transfusions. This
observation suggests that individual suscentibilit
is more important than the multlnlicity and spacing
of transfusions in determining the indidence of iso
immunisation in case of routine blood transfusion
in hospital practice.
Since it is not practicable to screen all the
"
antigens involved in causing iso-immunisation nor
to determine the individual susceptibility at
present, it may be concluded in view of the above
findings that -
(1) blood transfusion should be practiced only
when properly indicated, keeping in mind that the
chance of immunisation Is greater in previously
transfused patients; (2) consideration should be
given to the advisability of introducing a routine
screening for antibodies (a) after the second
transfusion in oatients who are likely to require
blood in future, (b) after transfusion in women
who are likely to have further pregnancies.
Anamnestic Reaction
A non-specific rise was observed in two
cases (Nos. 26V and 271) where the anti-D titres
increased following the transfusion of D-negative
blood. Opinion varies as tc the effect of non¬
specific stimuli on the tltre of antibodies.
van Loghem(1948) used triplo and tetra-vaccines
as/
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as non-specific stimuli and considered that
suitable volunteers for immunisation to Rh could
be selected by choosing those who gave clinical
reactions to preliminary injection of vaccine.
Vtiener(1951b) on the other hand, was unable to
confirm the phenomenon of anamnestic rise of
antibody titre, as in eleven cases of previously
immunised Rh-negative mothers he could not find
any rise of antibody(anti-D) titre as a result of
pregnanoy with an Rh-negative foetus. Cochrane
and his co-workers(1950) ho ever, ere able to
demonstrate the rise in anti-Kell antibody in a
mother following the birth of a Kell-negative
baby, the mother was previously sensitized, by
transfusion of Kell-positive blood.
It seems from the above findings that in some
cases at least, there may be a rise in antibody
titre by non-specific stimuli and this point should
be taken into consideration in all cases of
sensitized pregnant women requiring transfusion,
since the non-specific rise in the antibody titre
even after compatible blood transfusion may pre-
:cipltate or aggravate the haemolytic condition
in the foetus.
Persistence of antibody
Once developed, anti-D antibodies persist in
the circulation for very long periods; for ex-
sample, Stratton(1955) reported a case in which
anti-D/
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antl-D was found in a woman 38 years after her
last pregnancy. In the present series, anti-D
was detected in the sera of a man (Case 867) after
7 years following the transfusion of 2 bottles of
blood. The persistence of antibodies is of
importance because, if an antibody other than
anti-D develops it may also remain in the cir¬
culation for some considerable time and the use
of Rh-negative group 0 blood without cross match-
:ing test (as sometimes done in case of extreme
emergency) may not be safe.
'Dosage effect*
The serum of case 14. containing snti-e
antibody showed 'dosage effect'. Such effects
have also been reported in cases of, anti-M by
Landsteiner and Levine(1928), anti-E by Malone
and Dunsford(1951;, anti-S by Levine et al.(1952)
and antl-Fy* by Race and Sanger(1954). These
observations suggest thrt care should be taken in
selecting test cell panels, since some of the
antisere, particularly with low titres may give
rise to false negative results with heterozygous
cells (in relation to the antigen concerned).
Specific irregular cold agglutinins
Prom the results of present investigations
as well as from those of other workers, it seems
that anti-Lewis (particularly anti-Lea) and anti-P
antibodies/
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entibodies are more common findings in the human
sera then sntl-M and. enti-N, In the present
series of 712 samples no anti-M or anti-N was de-
:tected while anti-Lewis antibodies were found in
approximately 1*6% of the cases examined - an in-
icldence higher than previously reported results.
Kissmeyer-Nielsen and his co-workers(1955) found
68 anti-Lewis antibodies in a series of 17,000
oases - an Incidence of 1 in 300. The frequenoy
of anti-Lewis antibodies in the present material
may be caused by combination of two factors:
(1) antigenic structure of test cells - Le(s+) and
Le(bt-) cells having been used during the whole
investigation, (2) and testing all the sera at
room temperature. (In Kissmeyer-Nielsen and his
co-workers1 series 1,200 samples wore tested at
room temperature). Anti-Le is for commoner
than anti-Le^ as noted by Pettenkofer and Hoffbsuer
(1954J f:nd this has also been observed in the
present series that the proportion of these two
antibodies was 8:2.
Although some of these patients with anti-
Lewis antibodies in their sera had histories
suggestive of previous immunisation, it seemed from
the nature of reaction that all the antibodies
(with the execution of immune anti-Le^ which de¬
veloped in the sera of cose 211. following/
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following the present transfusion) were of
spontaneous origin. Only one of these antibodies
caused haemolysis of specific red cells on trypsin
treatment, a finding at variance with that of
Kosenfield and Vogel(1951); the low potency of
most of the anti-Lewis antibodies in the recent,
series may be the cause of difference between these
findings. It is a common experience that anti-A
and anti-B titres rise after ABO incompatible
transfusion and one could therefore expect that
such a rise would occur in cases of incompatible
transfusions in relation to Lewis blood groups.
On the contrary, none of the six patients with
anti-Lewis antibodies in their sera who received
Lewis incompatible blood shoved any rise In
antibody titre - which indicates that the titres
of all types of naturally occuring antibodies do
not rise following specific stimulation. It was
also noted that none of these pstients suffered
from any reaction folio ing the transfusion.
Anti-P antibodies were detected in the sera
of only two patients - a low incidence since,
Henningsen(1949) found that if enti-P Is looked
for with a suitably sensitive technique, anti-P
antibody could be detected in the sera of P-neg¬
ative persons with a regularity almost approach¬
ing that of agglutinins of the ABO system.
However/
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However, no special sensitive technique (as
recommended by Hennlngsen) was used to detect
anti-P, but it can be stated from tne results of
the present observation that anti-Lev is antibodies
are more readily detected than anti-P.
Although the naturally occurring anti-Lewis
and anti-P antibodies are not clinically important
they may give rise to confusion in cross matching
tests and this point should always be considered
in carrying out these tests particularly when they
are done at room temperature.
Non-specific cold agglutinins
Non-soecific cold agglutinins were found in
about 79# of the pre-transfusion samples. The
majority of the patients with cold agglutinins in
their sera received blood transfusions during the
present investigation but only one case, a case of
haemolytic anaemia, (Case 14.) showed any rise of
cold agglutinin titre in the post-transfusion
sample. No correlation between the presence of
lo ? titre non-specific cold agglutinin and disease
age or sex of the patient or previous history
suggestive of immunisation was observed. However
it was noted that the cold agglutinin titres in
group A, B, and AB persons were comparatively
higher than those in group 0 persons - a similar
observation made by Mollison(1956).
Relative/
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Relatlve merits of different methods used for
detection of Incomplete antibodies
Of the methods used for the detection of
Incomplete antibodies the albumin method was found
to be least sensitive. Moreover, it failed to
detect antibodies not only of the Rh system
(anti-c, Case 152) but also anti-Rell (Case 5) and
anti-Fy® (Cases 267 and 281)»
Trypsin-treated cells are said to be very
suitable as far as the antibodies of the Rh system
are concerned and Rosenfield and Vogel(1951) and
Vliener and Kstz(1951) reported that they did not
observe an instance of "Rh-Hr sensitization" that
had not been detectable by trypsin-treated cells.
Ho ever, it was rather unusual that an anti-e
antibody (Case 14) in the present series could not
be detected by trypsin-treated cells and it seems
possible thnt on very rare occasions trypsin-
treated cells may fail to detect some of the
antibodies of the Rh system.
The importance of the indirect Coombs' test
for the detection of incomplete antibodies is veil
established and this has been demonstrated in the
present series that anti-K (Case 3), anti-c (Case
152) and anti-Fya (Cases 267 and 281) could not
have been detected if the indirect Coombs'
technique had not been used. It should be noted
in/
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in this connection that the dilution of anti-human
globulin sera which is optimum for the detection
of Rh antibodies may not necessarily be always the
same as for the other blood group antibodies (c.f.
Case 281) and it is therefore important to put up
controls with other blood group factors (e.g. Kell
Duffy) in addition to D factor in carrying out
Coombs' technique.
Although the results of the simplified papain
method compared favourably with those by indirect
Coombs' technique, it is difficult to draw any
conclusion from the results of the present series
(as well as from those of Tribedl and Crosbie's
series in which the same batch of papain was used)
because one batch of papain was used during this
investigation and it is known that the activity
of different batches of papain may vary. However
since the papain method used in this Investigation
is simple, sensitive and less time-consuming,
further trial with different batches of papain
may be carried out by other workers to confirm
the results of the present findings.
In view of the above observations, it may be
concluded that until the perfection of some simple
method (e.g. Papain method), Coombs' test must be
used to detect Incomplete blood group antibodies





An investigation has been carried out to
observe the incidence of iso-immunisation as a
result of routine blood transfusion. By the use
of various methods end standard cells containing
most of the clinically important blood factors,
an attempt has been made to detect as many as
possible of the cases of blood group sensitivity
resulting from transfusions covered by cross
matching tests at present in use.
I •
To establish that an antibody detected in
post-transfusion sample, vas not present in the
patient's serum prior to the present transfusion,
a pre-transfusion sample of every prospective
recipient was screened.
In examining the sera of 712 such recipients,
non-specific cold agglutinins were detected in
79% of cases. Bleven patients showed anti-Lewis
and two anti-P antibodies in their sera - all of
which seemed to be naturally occurring. Some of
the patients with anti-Lewis antibody in their
sera received Lewis incompatible blood transfusions
during the present observation but there as no
reaction or rise in anti-Lewis titre in any of
these cases following transfusions.
The significance of these antibodies in




Six of the 302 patients who received blood
transfusions during the present investigation
developed immune antibodies of different specific-
titles - an incidence of approximately 2% which
is much higher than the published figures obtained
during the course of routine blood bank work deal-
ting with the investigations of transfusion
reactions and cross matching difficulties.
As expected, it was found that the incidence
of immunisation among previously transfused
patients is much higher than among those who had
no previous transfusion. It was also noted that
individual susceptibility is more important than
the number and spacing of transfusions in deter¬
mining the incidence of iso-immunlsation.
Importance of these findings in relation to
the increasing number of "repeat" cases In routine
transfusions in hospital practice has been discussed.
An observation in the present study that
transfusion is a better stimulus than pregnancy
sup orts the similar finding of previous workers.
It has also been found that every case of
blood group sensitivity cannot be detected by the
methods used at present.
In two cases an anamnestic rise In antibody
titre was observed - a fact which may be of
importance/
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importance in the transfusion of pregnant women.
The relative merits of different methods for the
deteotion of incomplete antibodies have been
compared. It was noted that the optimum dilution
of the Coombs• serum for the detection of different
incomplete antibodies may vary.
A simple papain method which has been found
to give satisfactory results, comparable to those
by Coombs' test, is described.
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IT. STUDIES ON THE AGGLUTINABILITY OF
STORBD RED BLOOD CELLS.
CONTENTS.
INTRODUCTION I.





With the discovery of various blood group
systems, e test cell panel is becoming an increas-
:ingly important necessity in the research lab¬
oratories dealing with blood group serology.
A test cell panel is also an important tool of the
equipment required in routine blood bank work to
solve the increasingly frequent problems of trans-
;fusions in patients with blood group sensitivity.
As erythrocytes lose their agglutinating property
with storage, it has been necessary to draw fresh
blood samples from the donors at frequent inter¬
nals to maintain such a cell panel.
The recent discovery of a method of preserv-
:ing cells by freezing in presence of glycerol has
been of great value, as it has permitted laboratory
storage of blood group antigens for prolonged
periods. Preservation of cells in frozen con¬
dition followed the discovery of Polge, Smith and
Parkes(1949), that spermatozoa survived freezing
for long periods if treated with glycerol. This
discovery was extended by Smith(1950) who observed
that in rabbit and human blood diluted with equal
parts of 30% glycerol-saline, and frozen at -79°C.,




usually caused by freezing and thaving. Human
red cells so treated can be freed from glycerol
and recovered in aoperent normal condition in
yields of BO to 90$ of their original number
(Sloviter,1951). Mollison and Slovlter(195l)
first used this method for transfusion studies in
man and they found no significant effect on the
post-transfusion survival of red cells stored at
-79°C. for two to three hours. Subsequent work
on the storage of red cells in the frozen state
was reviewed by Mollison, Sloviter and Chaplin(1952)
who described the results of exoeriments in which
red cells were stored at -15°G. or -79°C. for six
months and then used for transfusion, Krijnen
and his collaborators(1952) using this method
observed the effects of such freezing at -79°C.
on the agglutinability of the red cell antigens
(A, B, M, N, S, G, D, K, c, Lea, Le^, FyR) and
found no change during a storage period of four
months. The method has since been elaborated
and rapidly develooed by several workers and it
has now reached the stage of considerable practical
use for oreserving red cell samples. Chaplin,
Cutbush, Crawford and Mollison(1954) preserved
red cells in glycerol-citrste mixture at -20°G.
and observed that the red cell antigens (A, B, D,
c, a, M, N, S, LeP, Leb, Lu*, Fy&» K) reacted
specifically,
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speclficfllly with blood group sera even after a
year although the reactions were only slightly
diminished. Grove-Rasmussen et al.(1953) used
both glycerol-citrnte and glycerol-lactate
solutions as advocated by Brown and Herdin(1953)
and preserved the cells at -16°C. to -18°G. and
found no change in agglutinability in a wide range
of blood group antigens during a 20 week storage
period.
Thus it is well established that the red cells
frozen in glycerol maintain their specific agglut-
rinstion reaction (with resoect to almost all the
blood group antigens) for prolonged periods. In
the present method therefore, glycerol-treated
frozen cells \<ere used as controls.
While all the workers agree on the stability
of specific agglutination reaction of the red cells
stored in frozen condition, opinions very to
such effect on their storage in citrate solution
at 4° - 6°C.
Hattersley and Fa cett(1948) used AGO and
Alsever's solutions and found them suitable for
preserving whole blood of various antigenic types
for approximately seven weeks. Wall and his
associates(1950) used modified Alsever's solution
and they did not find any decrease in agglutin-
:ability/
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agglutinability (with the exception of A0 cells)
within two months. Simmons and his co-workers(1951)
used a glucose-citrate solution in distilled water
(modified Rous-Turner solution; in their snthro-
rpological studies and were able to preserve
sgglutinsbility in their blood samples for more
than six months. Mijenhuls(1953) on the other
hand, used Simmons' solution and observed that the
agglutinebility of the red cells deteriorated after
a storage period of only one and a half weeks.
Kooptzoff(1954) stored blood in four different
fluids at 4° -6°C. and examined them at three day
intervals up to 21 days and found that agglutin-
sability of all the red cell antigens (A, B and D)
decreased on storage in all the solutions studied.
The above results are summarised in the
following Table/
-5-

















































A, B, D Decreased within
21 days in all
the solutions
used
Crawford, Cutbueh end Mollison(1954) compared the agglutinability of red cells
from clotted samples, and those preserved in ACD solution, and frozen in glycerol
at -?0oC., and in view of their findings, reconsnended that if red cells are to be
kept for more than two weeks, it is best to preserve them in frozen condition at
-20°C. in presence of glycerol.
The/
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The question of stability of agglutination
reaction of red cells preserved in AGD solution
is of importance because, blood samnles stored in
such solution are often used for grouping and
cross matching tests. Moreover when old cells
stored in ACD solution are used for the detection
of cases of blood group sensitivity, antibodies
may be missed - a probable explanation of the
cause of failure to detect antibodies in some
cases of apparent haemolytic reactions (see Part I),
Under the circumstances, it is orth study-
sing the problem in more detail and investigations
ere therefore undertaken to observe the loss of
sgglutinability on storage under blood bank con-
sditions using high titre antibodies against a






Blood from donors with previous history of
malaria were selected sg they are not used for
transfusion purposes. 400 ml. of blood was with¬
drawn in the usual way in MRC bottles each con¬
taining 110 ml. of AGD solution (Dextrose - 3 gm.,
Trisodlum citrate - 2.7 gm., Distilled water -
100 ml.) and stored at 4° - 6°G.
Second. Series:
In this series specimens were obtained during
routine withdrawal of blood from the donors in
specially sterilized one ounce vials with strict
aseptic precautions. 10 ml. of blood was with-
sdrawn in each vial containing 2.8 ml. of ACD
solution. The proportion of blood and AGD solut¬
ion was therefore the same as in case of with¬
drawal of blood for transfusion purposes. These
samples were also stored at 4° - 6°G.
Olycerol-cltrate Mixture:
It was prepared by mixing 4 volumes of
glycerol and 6 volumes of b% trisodium citrate
solution.
Methods used for freezing the cells in
glycerol-citrate mixture and their recovery after-
swards/
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afterwards are those of Mollison, described by
Race and Sanger(1954).
Freezing of Cells In Glycerol-citrate Mixture:
Donor's blood (First Series), stored at
4° - 6°C. were usually obtained from the Blood
Transfusion Service on the third day following
collection. On receiving the bottles, viscaps
were removed and 20 ml. of blood was withdrawn
from e«ch bottle with aseptic precautions with a
syringe, by piercing the rubber diaphragm. After
replacing the viscap the bottle containing the
remaining portion of blood was immediately re-
:moved to the cold storage room (4° - 6®G.).
10 ml. of blood from the syringe was placed in
each of the two sterile test tubes and centrifuged
at 3,000 rpm. for 30 minutes. The supernatant
plasma was removed as completely as possible and
one ml. of packed cell was placed in each of 8
sterile test tubes. (The remaining portion of the
blood was used to find out the initial titre as
stated below). To each of eight test tubes con-
staining packed red cells one ml. of glycerol-
citrate mixture was added drop by drop with con¬
st inuous agitation. The tubes were then stopper¬
ed and frozen at -20°C.
Recovery of Gells:
Four solutions containing respectively 16$.
8$,/
-9-
8%, 4% and 2% glycerol (w/v) in 3$ citrate solut-
:ion were prepared. On every fourth day one tube
of blood was thawed by placing it in a water-bath
at 37°0. and then centrifuged at 3,000 rpm. for
10 minutes. The supernatant fluid was replaced
by a solution (about ten times the volume of the
packed cells) containing 16$ glycerol in 3$
sodium citrate. The solution and red cells vere
mixed and then immediately centrifuged again,
supernatant fluid removed and the whole process
repeated with 8$, 4% and 2% glycerol in Z% citrate




On the third day following collection of
blood, titration was done on cells left after
preparation of glycerol-citrate-cell mixture
(initial titre). The cells were washed twice
and a 2% suspension was made in saline. There¬
after on every fourth day (up to 35th day)
titrations were carried out on thawed and washed
cells (from frozen samples) making a final 2%
suspension in saline. In parallel to this,
similar titrations on cells taken from the
original bottle on each occasion were also done.
For/
-10-
Por this purpose one ml. of blood was withdrawn
from each bottle in the same way as described above
and centrlfuged, supernatant plasms vaa removed,
the cells were washed twice and a 2% suspension
was mfide in s'line.
Titrations were carried out In tubes using
the doubling dilution method. In case of ^
and B antigens the tubes were incubated at room
temperature for 30 minutes. For the D agglutin¬
ogen, saline acting entl-D serar was used and the
tubes ere Incubated at 37°C. for two hours.
The results were re^d microscopically and the last
tube giving clumps of at least 8 to 12 cells was
recorded as the titre (MHG Memo.,No.£7). To
simplify the Tables, titres are expressed in
tubes (units) Instead of in actual figures and
the tube number representing actual titres "-re
as folio s:
Tube




(titres) 1:1 1:2 1:4 1:8 1:16 1:32 1:64
AC
1:128
For Kell(K) and Duffy(Pya) antigens blood
specimens were obtained on the day of lthdraval
and the initial titres were done on them on the
same day. Thereafter for these two antigens,
titres/
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tltree were done on every alternate day end the
indirect Coombs' method vr s employed, as the
enti-Kell end anti-Duffy sere used were of incomplete
type,
The same batch of anti-sera, respective of
each blood group was used throughout the tests.
Second Series:
Blood samples in this series were preserved
only in ROD solution and examined on the day of
collection, A second titration w s done on the
35th day to observe the deviation from the initial
titre. On each occasion one ml, of blood was
withdrawn from each vial, washed and a 2f suspen-
:sion made in saline as described above. The
same doubling dilution method was used for
titration. In addition to saline anti-D, an
incomplete anti-D sefcm was used: in this case
the titration w-s carried out by papain method.
The batch of saline ©riti-D sera used for this
series was different from th"t used in the case
of the first aeries,
isvery day before titration, the specificity
of reaction of each sample of stored red blood
cells was checked with control sera. *11 the





Erythrocytes frozen at -20°G. in presence of
glycerol-citrste mixture did not show any loss of
agglutinating property of the antigens tested up
to 55 days. On the other hand, varying degrees
of loss of agglutinebility were observed on red
cells preserved in ACD solution at 4° - 6°C.
and A^. antigens
18 group A, and three group Ar bloods were
preserved both in ACD solution and glycerol-
citrate mixture (GCM). The results of titrations
on these bloods against anti-A serum are shown in




Sp.ilo. Days of storage
3 7 11 15 19 23 27 31 35
1. ACD 11 11 11 10 10 10 10 9 9
GCM 11 11 10 10 10 11 10 11
2. ACD 10 10 10 10 9 10 10 9 8
GCM 10 10 10 10 10 10 9 10
3. ACD 12 12 12 11 11 11 10 11 10
GCM 12 12 12 11 12 11 11 11
4. ACD 10 10 10 10 9 9 9 9 8
GCM 10 10 10 11 10 10 9 10
5. ACD 10 10 10 10 9 9 9 9 8
GCM 10 10 10 11 10 10 9 10
6. ACD 11 11 ID 10 10 10 9 9 8
GCM 10 10 10 10 10 9 10 10
7. ACD 10 10 10 10 9 9 9 9 9
GCM 10 10 10 10 10 9 10 9
8. ACD 11 11 11 10 10 10 10 10 8
GCM 11 12 11 11 11 11 11 11
9. ACD 10 10 11 9 9 9 8 8 8
GCM 10 10 10 10 10 10 9 10
10. ACD 11 11 11 10 10 10 11 9 9
GCM 11 11 11 11 12 11 11 11
11. ACD 10 10 9 9 9 10 9 8 8
GCM 10 10 10 10 10 10 9 10
12. ACD 10 10 10 10 10 9 8 7 7
GCM 10 10 10 10 10 10 10 10
Table 1/
Table I (Contd.)
Sp.no. Days of storage
3 7 11 15 19 23 27 31 35
13. .ACD 1? 12 11 11 10 10 9 9 8
GCM 12 12 12 12 12 11 12 11
14. ACD 11 11 10 10 12 10 10 9 9
GCM 11 11 11 11 11 10 10 11
15. ACD 11 11 10 10 10 8 8 8 7
GCM 11 11 11 11 11 11 11 11
16. ACD 10 10 10 9 9 6 8 7 6
GCM 10 10 10 11 9 9 9 10
17. ACD 10 10 9 9 8 8 7 7 7
GCM 10 10 10 10 10 11 10 10
18. ACD 10 9 9 9 8 9 8 8 8
GCM 10 10 10 10 10 10 10 10
Table X. Titres on cells on different dates against enti-A serum .
Titres are expressed in urate (tubes).
ACD and GCM indicate cells preserved in ACD solution at 4° to 6°C.,
and cells frozen at -20°C. in glycerol-citrate mixture, respectively
Table II (a)/
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Sp.no. Days of Storage
3 7 11 15 19 23 27 31 35
1. ACD 8 7 6 6 5 5 4 4 3
GCM 8 8 8 8 9 8 8 8
2. ACD 10 8 7 6 5 4 3 3 2
GCM 10 9 9 10 10 9 10 10
5. ACD 8 6 5 5 § 4 3 2 2
GCM 8 9 8 8 8 9 8 8
Table 11(a). Titres on Ag cells with sntl-A
aero. See legend Table I.
The deviations of the titres from the controls
(initial titres) are sho n in Table 11(b). A unit
of deviation represents one two-fold (1 tube)
dilution of anti-sera. One unit deviation is the
commonly accepted error of the pipette dilution
method. iSnd point titre changes of more than
1 unit thus indicate changes in specific
agglutinability of the stored red cells.
Sp. no. Days of Storage
7 11 15 19 23 27 31 35
1. ACD -1 -2 -2 -3 -3 -4 -4 -5
GCM 0 0 0 -<-1 0 0 0
2. ACD -2 -3 -4 -5 -6 -7 -7 -8
GCM 0-1-1 0 0-1 0 0
3. ACD -2 -3 -3 -4 -4 -5 -6 -6
GCM 0+1 0 0 0+1. 0 0
Table 11(b). Deviations from the controls
(initial titres) of the titres
on Ag cells in Table 11(a).
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None of the 21 group A cells (18 group end
three group Ajg) preserved In glycerol-citrate
mixture sho.ed a deviation beyond one unit (Pig.l.)
which is within the error of the pipette dilution
method.
In the case of erythrocytes preserved in
ACD solution, all the 18 group bloods showed
only a small loss in agglutinsbility (maximum loss
in titre: 4 tubes), whereas three bloods showed
a rapid and marked loss of agglutinating power
as shown in Pig.2.
o -I
Loss of titres in units (tubes)
Loss of titres in units (tubes)

















The loss of agglutinability against anti-ft
serum of A-^ and Ag cells preserved by two methods
has been compared in Figures 3 and 4., one typical























3 7 II 15 19 23 27 31 35
Days of storage
Cells preserved in A.C.D. solution 0----0















3 7 II 15 19 23 27 31 35
Days of storage
Cells preserved in A£D. solution o o
Cells frozen in glycerol-citrate mixture* •
Figs. 3 and 4. The difference in loss of
agglutinability against anti-A
serum of A1 (Specimen No.9,
Table I) arid A cells (Specimen
No.2, Table IX (a) ) preserved
In ACD solution and glycerol-
cltrate mixture.
The loss of tltre in case of antigens was
only t o tubes on 35th day where as in case of A,^
antigens It was 8 tubes. In glycerol-treeted




Tltres on B cells against anti-B serum on different
dates are tabulated in Table III. No appreciable loss
of titres was observed vithin the study period in cells
frozen in glycerol-citrate mixture. On the other hand
all seven group B bloods, preserved in ACD solution,
lost their agglutinating property to a certain extent.
Table III
Sp.no. Days of storage
3 7 11 15 19 23 27 31 35
1. ACD 10 10 10 9 9 9 9 8 8
GCM 10 10 10 10 10 10 10 10
2. ACD 9 8 8 8 8 8 8 7 7
GCM 9 9 9 9 9 9 9 9
3. ACD 9 9 9 8 8 8 8 8 7
GCM 9 9 10 9 9 9 9 9
4. ACD 8 8 7 7 7 6 6 6 5
GCM 8 9 8 7 8 8 7 7
5. ACD 10 10 9 9 9 9 8 8 8
GCM 10 10 10 11 9 10 11 9
6. ACD 9 9 8 8 8 8 7 7 7
GCM 9 8 9 9 9 9 10 9
71 ACD 10 9 9 9 8 8 8 8 8
GCM 10 10 10 10 9 10 10 10
Table III. Titres on B cells with antl-B sera.
See legend Table I.
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Kell and Duffy antigens
Only one sample each for Kell(K) and Duffy(Fya)
antigens was preserved by the above methods. Neither
antigen, preserved in ACD, could be detected on the
7th and 11th day respectively (Figures 6 and 6)
although they gave as strong reactions as initial
titres even up to 21 days when they were preserved in
glycerol-citrate mixture.
Fig. 5
Cells preserved in AjCD. solution o—-o










Cells preserved in AC.D. solution o—--o
Cells preserved in glycerol-citrate mixture • *
Figures 5 and 6, Titres on cells preserved by two methods




The results of titrations with snti-D serum
on 19 D-pcsltive bloods preserved by two methods
are shown In Table IV, Ten of these samples
(nos, 1,2,4,5,8,9,10,11,14 and 19, Table IV)
preserved In ACD solution shoved marked loss of
agglutinability while the remaining 9 bloods were
more stable
There appeared to be s distinct division
between these two types, suggesting the existenoe
of two varieties of D antigen - a stable and an
unstable one. This division into two groups is




Sp.No. ABO Days of storage
group 3 7 11 15 19 23 27 31 35
1. 0 ACD 8 7 7 6 4 4 3 2 1
GCM 8 8 8 8 9 6 8 7
2. 0 ACD 9 8 7 6 4 3 3 2 2
GCM 9 9 9 9 8 9 9 8
3. 0 ACD 8 8 8 7 7 7 7 6 6
GCM 8 8 8 7 8 8 9 8
4. 0 ACD 10 8 8 7 6 4 3 2 2
GCM 10 10 11 10 10 9 9 10
5. 0 ACD 9 7 6 4 4 3 2 1 1
GCM 9 9 8 9 8 8 9 8
6. 0 ACD 9 9 8 8 9 8 8 8 7
GCM 9 9 9 9 9 9 9 9
7. 0 ACD 7 7 7 7 7 6 6 6 6
GCM 7 7 7 7 7 7 7 7
8. A1 ACD 9 7 6 4 2 2 1 1 1X
GCM 9 9 9 9 8 9 9 9
9. A1 ACD 8 6 5 5 4 3 3 2 2
GCM 8 8 7 8 8 7 8 7
10. A1 ACD 9 7 5 4 3 3 2 1 1
GCM 9 9 9 8 9 8 8 9
11. A2 ACD 9 8 7 6 4 4 2 2 2
GCM 9 9 8 9 9 9 9 9
12. A2 ACD 8 8 8 8 7 7 7 8 7
GCM 8 9 8 8 7 8 8 8
Table IV/
Mr IY (Contd.)
Sp.No. ABO Days of storage
group 3 7 11 15 19 23 27 31 35
13. B ACD 9 9 9 8 8 8 8 8 8
GCM 10 10 10 10 9 10 9 10
14. B ACD 10 8 7 7 5 4 3 2 2
GCM 10 10 10 11 9 10 9 10
15. B ACD 9 9 9 8 8 9 9 8 8
GCM 9 9 9 9 9 9 9 9
16. a2 ACD 9 8 8 8 7 8 8 7 8
GCM 9 9 9 9 8 9 9 9
17. A1 ACD 9 9 9 8 8 8 9 9 8
GCM 8 8 8 8 8 8 8 8
CO • AlB ACD 8 8 8 7 7 7 7 7 7
GCM 8 8 8 8 8 8 8 8
19. A. B ACD 8 6 4 3 3 3 2 1 1
1
GCM 8 8 8 e 7 8 8 8
Table IV. litres on D antigens (of 19 D-positive bloods in the first
series) on different dates. See legend, Table I.
No loss/
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Fig.7. Loss of titres against anti-D serum on
35th day by 19 D-positive bloods (First
Series) preserved in ACD solution at 4 -6°C.
No loss of sgglutinability of D antigens was
observed in any of the 19 D-positive bloods frozen
in glycerol-citrnte mixture as sho-n in Table IV
and Fig.8.
Fig. 8
♦ i o -I
Loss of titrcs in
units (tubes)
Fig.R. Loss of titres against anti-D serum on
35th day by 19 D-posItlve bloods frozen
in glycerol-citrate mixture at -20°C.
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Pigure 9, a typical example from the more
stable group sho%s the progressive loss of activity
in the course of 35 days period. The final loss
of titre on the sample preserved in ACD solution
was only two tubes on the 35th day. In the ex-
:ample in Figure 10., from the less stable group
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3 7 II 15 19 23 27 31 35
Days of storage
Cells preserved in glycerol-citrate mixture • «
Cells preserved in A&D. solution o-—-o




3 7 II 15 19 23 27 31 35
.1 Days of storage
Cells preserved in glycerol-citrate mixture » »
Cells preserved in A£.Cl solution , o----o
Fig.10. Titres given by one of the less stable
D antigens (Nol Table IV)
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Second Series:
Irx view of the results on D antigens in the
first series, a further Investigation was carried
out on a second series of 28 D-posltive cells to
ascertain whether the division into two classes
of the D agglutinogens would be maintained; and
also to see if this division could be correlated
with any other factor. The zygosity in relation
to D factor, ABO groups, and the age and sex of
the donors of this series were noted, As it was
found that the red cells preserved in frozen con¬
dition do not lose agglutinability up to 35 days,
the samples in the second series were stored only
in ACD solution.
Kesults of titrations of 28 D positive cells
both against saline antl-D and incomplete anti-D
(by papain method; are tabulated in Table V.
Deviations of the titres from the originals on
35th day are also shown.
Table 7
Sp.No. AliO Op. Age Sex Titree on Deviation
let day 35th day



























































































Sp.No. ABO group Age Sex Titres on Deviation
1st day 35th day






























































































Table v. Titration results against anti-D sera on 28 D-positive bloods (second
series) preserved in ACD solution. Titres in units (tubes) as obtained
on 1st and 35th day are tabulated. Deviations of the titres from the
controls(titres obtained on tne first day) on 35th day and Rh genotypes
of last 8 bloods are also shown.
S - - - titres against saline anti-D serum
P titres against incomplete anti-D serum (by papain method)
Of/
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Of 28 specimens twelve (Nos. 22, 24, 26, 27, 50, 52, 54, 59,
42, 45, 45 end 47, Table V) showed marked loss of egglutinability
(4 units or more) on 55th day distinct from the remaining 16
(loss - 2 units or less). This is illustrated in Pig.11 which
represents the loss in titre against saline anti-D. It was also
noted that the loss in titre against saline nnti-D and incomplete
anti-D (by papain method) was uniform (see Table V) and a dis¬
tribution figure similar to Fig.11 is obtained with the loss in
titre against incomplete anti-D.
Pig.11. Loss of titres(against
saline anti-D) on 55th
day by 28 Rh(D) positive
bloods (Second Series)
preserved in ACD solution.
If the loss of titres over the period of 55 days for all D
antigens (preserved in ACD solution) studied, are gathered to-
jgether, the result is as shoftn in Fig.12 which confirms that the
division of the D antigens into two classes is maintained. The
distribution curve thus tends to show two maxima, one corresponding
to only a slight loss of agglutinability (one tube) end the other






O -I -2 -3 -4 -S -6 -7 -8
Loss of titris in units (tubes)
Fig.12# Loss of agglutinability against snti-D sera
by 47 D-positive cells (of both series 1 and 2)
preserved in "CD solution. In case of second
series titres only against saline anti-D sera
has been considered.
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Six of the ft samples with known Rh genotypes
were homozygous and two heterozygous with relation
to the D factor (Table V). Three homozygous and
one heterozygous bloods lost agglutinability to a
marked degree while the rest (three homozygous and
one heterozygous) were more stable. This suggests
that the loss of agglutinability is not related to
the homo- or heterozygosity of the D factor.
The initial titres on both stable and unstable
D antigens varied from 7 to 9 and 8 to 10 tubes
respectively in the first series (Table XV, titres
on cells preserved in ACD solution) and in both
types of antigens they varied from 6 to 9 tubes in
the second series (Table V, titres against saline
anti-DJ. The loss in titres was not due to de¬
terioration of the anti-sera was proved by (1)
adequate controls and (2) the use of three differ¬
ent antisera. No relation was found between the
stability of the antigen and the initial titre.
It was also observed that the loss of
agglutinating poer was not related to the age
and sex (Table V) and ABO groups (Tables IV and
V) of donors of the cells.
-28-
DISCUSSION
Storage of red blood cells In the frozen state
in a glycerol-citrate mixture has been reported to
give preservation of agglutinability, This method
was therefore used as a control in the present
study on storage of red cells in AGO solutions.
In the frozen glycerol-citrate controls the de-
iviatlon of agglutinability was found to be within
the limit of error of pipette dilution titration,
confirming the observations of previous workers.
The controls served to verify that the anti-sera
used were maintaining full titre over the period
of storage of the cells. None of the A-^, a^, B,
D, Kell and Duffy antigens (of frozen samples)
Investigated, showed any loss of agglutination
reaction during 35 days study period. The
agglutinability of the erythrocytes preserved in
ACD solution on the other hand, deteriorated with-
:ln the same period and therefore, if storage of
test cells is necessary it Is desirable that they
should be preserved in frozen state In glycerol-
citrate mixture.
The degree of loss of agglutinability of the
red cells preserved in AGD solution varied with,
different blood groups. A-^ and B antigens were
stable and Ag, Kell and Duffy were unstable.
Wall et al.{1950) in their study on specific
agglutInability/
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agglutinability of red cells noted that Ag
agglutinogen to be least stable. The present
finding that all 5 Ag bloods showed rapid and
marked deterioration of agglutinability coroborates
their observation.
In the case of D antigens in the first series
it wfi s noticed that all the D positive cells did
not lose their agglutinating power to the same
extent when preserved in ACD solution. On the
basis of loss of agglutinabijity they appeared to
fall into two classes - one undergoing rapid loss
of agglutinability and the other being comparativef
sly stable. This is illustrated in Fig.7. This
observation was confirmed by a further study on
28 D-positive cells in the second series. 12
bloods in this series also showed more marked loss
of agglutinability. Taking both the series to-
:gether 22 (approximately 47$) out of 47 D-positive
bloods could be distinguished from the rest on the
basis of greater loss of agglutinability as a
result of storage (see Fig.12).
An attempt was made to correlate this div¬
ision of D antigen into two groups with various
factors likely to give an approximately 50#
distribution. However, no correlation was found
with any of the factors investigated: age, sex
and ABO groups of the donors, homo- or hetero¬
zygosity of the cell with relation to the D factor
or chromosome frequency, and also the initial titres.
Little/
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Little previous work has been published on
the variations in agglutinability of the D antigen
as a result of storage. Ho*ever, compared with
ABO antigens it has been found by some authors
that D antigen is less stable, Kooptzoff(1954)
noted that the 3> antigen lost its agglutinability
at a faster rate than A and B antigens when the
red cells were stored in citrate solutions at
4° - 6°C.
Nothing much is known of the reason for in-
:stability of the antigens when the cells are
preserved in citrate solution. However, the
observations of Wiener(1943), Nijenhuis(1953) and
Kooptzoff(1954) that if the concentration of the
blood in the preserving fluid was low, the
agglutinability of the antigens decreased at a
faster rate than if the concentration of the blood
was high, suggest th? t the citrate solution may-
have some direct or indirect action on the agglut-
:inating property of the red cell antigens. It
may also be possible that the loss of agglutin-
:ability is due to certain elements in the plasma
e.g. enzymes or due to ultimate pH of the stored
blood. These factors, however, were not studied
in the present investigation.
It/
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It la not known with certainty whether the
©gglutinability of the red cells is directly re¬
lated to their antigenic power. It may be poss-
:ible that on storage agglutinability may be lost
as well as antigenicity. If it is so, then the
above observations indicate one of the possible
reasons for the finding that transfusion of in-
:compatible blood (with the exception of ABO groups)
is not necessarily followed by sensitization (see
Part I). Some of the blood transfused during the
second or third week of storage may lost antigenic
potency and may be less likely to stimulate antl-
sbody formation or to cause reaction than compar-
:atively fresh blood.
If on the other hand, red cells losing agglut-
:inahility, retain still their antigenic potency
to stimulate antibody formation, It is of practical,
importance in cross matching tests for transfusion
of blood. Some of the antigens (K and Pya in this
series) may deteriorate so quickly that they may
not be detectable within a few days of storage in
ACD solution. Although no complete loss of
agglutinability In the case of D antigen was ob¬
served in this investigation (possibly due to
high titre of the anti-sera used) Renton and
Stratton(1950) reported false D-negative results
with some anti-D sera when testing with old
specimens./
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specimens. In such cases false negative results
may be obtained If the bloods are cross matched
after a few days of storage and specially if the
antibody is very weak.
Prom the above findings It can be concluded
that further consideration should be given to the
question of deterioration of agglutination capacity
in blood intended for transfusion.
The present practice is to collect a separate
sample of blood at the time of withdra-al from the
donor and to use the cells from this sample for
compatibility(or to enter the bottle for the same
purpose). The latter test is intended to confirm
(1) that there has been no error in the ABO group-
%
:lng of the donor or the patient, (2) to confirm
that the patient's blood does not contain anti-
:bodies which would react with the donor's cells.
However, since the donor's cells may have been
stored up to three weeks, the possibility arises
that the cell antigens may have lost their agglut¬
inating capacity. In this case no reaction
would be obtained In the compatibility tests
soecially in the case of very weak antibody and
the 'incompatible' blood transfused. Such blood
might or might not be involved In a haemolytic
reaction; it is probable that the antigen would
still be capable of causing further antibody re¬
sponse/
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response. Moreover, for the same reason, the use
of stored red cells (In ACD) of the donor for the
investigation of transfusion reaction may give rise
to false negative results.
In view of this situation, it is suggested
(1) that attempt should be made to find a preserv¬
ative solution for donor's blood specimens intend¬
ed for compatibility testing which will preserve
agglutinability for full three weeks, (2) that in
the meantime, Ibr. patients who are likely to have
antibodies, or who have antibodies which have not




Red cell antigens stored in ACD solution at
4° - 6°C. showed different degree of loss of
agglutinating po-er which varied according to diff¬
erent blood group systems. A-^ and B antigens
were found to be stable whereas A0 was unstable.
On the basis of loss of agglutinability, two types
of D antigens could be recognised - one stable and
the other relatively less so. Although approx
:imately 50$ of the D antigens were found to be
less stable, no correlation was observed between
the stability of this antigen and any of the factors
studied.
Kell(KJ and Duffy(Pya) antigens could not be
detected after a storage period of a few days.
•ffhe importance of such loss of specific agglutin-
:ability of the stored red blood cells in blood
transfusion practice has been discussed.
It has also been noted that none of the
A^, Ag, &, D, K and Fya antigens investigated,
sho ed any loss of agglutination reaction during
35 days study period, when the red cells were
stored in glycerol-citrate mixture at -20°C.
This finding confirms the observation of previous
workers that if red blood cells are to be kept for
more than a few days for serological studies, it
would be better to mix them with glycerol and
store at -20°G. •
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